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CHAPTER I
INTRODUCTION

CHAPTER I
INTRODUCTION

A.

HISTORY OF LEAD POISONING
Lead and its compounds have been used by man for at least six

thousand years (Brunton, 1937).

It was among the first metals known to the

early Hebrews, Egyptians, and Phoenicians and the symptoms of plumbism
were familiar to Greek, Roman, and Arabian physicians before the Christian
Era.

Hippocrates in 370 B. C. was the first to recognize lead's toxic prop-

erties and Nicander in the second century B. C. observed the relationship
of constipation, abdominal pain, and pallor to the action of lead on the body.
Over the years more has been written about the causation and symptomatology of poisoning by lead than by any other toxic agent (Johnstone,. 1966).
Modern interest in lead poisoning dates from the 17th and 18th centuries
when outbreaks of lead poisoning occurred throughout western Europe as a
result of the addition of lead to wine. to promote fermentation and because of
its use in the manufacture and storage of cider and in material for cooking· vessels and other household articles (Cantarow and Trumper, 1944).

Crato

in about 1600 attributed the colic which was common in Moravia to the use
of "falsified wine" and Citosis, a physician of Poitiers, in 1616 mentioned
bad wine which had been treated with lead as the cause of colic.

In 1745

Huxham dE;?scribed a disease appearing in Devonshire, England having
I

2

symptoms identical with true lead colic and this was traced by Sir George
Baker (1767) to the lead used in the manufacture and storage of cider.

A

similar type of colic of similar etiology occurred in Spain and was described
by Luzuriaga in 1796.
Tanquerel des Planches in 1839 published an epoch-making treatise
containing an accurate clinical description of lead poisoning and since Tanquerel' s time, little has been added to our clinic_al knowledge of lead poisoning.

This treatise was responsible for the initiation of a period of intensive

clinical and experimental investigation of lead poisoning and this research
is pr:esently continuing.
GilfiHa~

(1965) has recently linked lead poisoning with the fal.1 of the

Roman Empire.

The Roman upper class died out with great rapidity begin-

ning about the 2nd or 1st century B. C. and plumbism is believed to have
contributed to this decimation because the upper class commonly used leadlined pots, lead aqueducts, and lead containing paints, cosmetics, and home
prepared concoctions such as wine-mead.

The poorer classes could not

afford the luxury of using lead and were therefore spared lead's toxic effects.

B.

ABSORPTION OF LEAD

1.

Respiratory Tract

Emissions of lead into the atmosphere result from burning of leadbearing materials, industrial processes in which lead is used, re-entrain-

3

ment of lead-beari.ng soil, and combustion of lead-bearing fuels.

Gasoline

and coal are the two major lead-bearing fuels and coal combustion in the
Cincinnati area emits between 54 and 270 pounds of lead into the atmosphere
each day. depending on the amount of lead retained in the ash or air
cleaning equipment.

Combu.stidri of leaded-gasoline in the Cincinnati area

causes an emission of 1700 pounds of lead into the atmosphere per day
(McCaldin, 1966).
The atmospheric lead concentration of a general urban area ranges
from 1 to 3 p.g/m 3• while measurements taken near automobile traffic
increase to 40 ;ig/m 3 (U.S. D. H. E.W., 1965).

This indicates the importanci

of combustion of leaded-gasoline as a source of atmospheric lead pollution.
Kehoe (1964a) has calculated that the respiratory intake of lead by a
normal adult living in a large city is in the order of 30 to 40 ,ug per day.
Of this amount, 70 to 75% is discharged in the expired air and only 25 to 30%,
never more than 50%. is retained in the lungs a.nd absorbed.· The respiratory tract thus can account for an absorption of up to 20 _.ug of lead each day.
A number of factors influence the absorption of lead by the respiratory
tract.

Among these are particle size and density,· r·ate and depth of breath-

ing, duration of exposure to the

lead~

and the hygroscopic nature of the lead

particle (Tomashefski and Mitchell, 1966).

The early studies of Goadby and

Goodbody (1909) and of Blumgart (1923-24) have shown that even relatively

4

insoluble lead compounds can be absorbed by the respiratory tract from the
nasopharynx to the pulmonary alveoli.

Robinson et al. (cited by Tomashef-

ski and Mitchell, 1966) have found that the particle size of atmospheric
lead in the Los Angeles area is of such a magnitude that it reaches the
alveoli where deposition, retention, and absorption via the lungs can occur.
A total of 60% of the atmospheric lead particles were found to have a
diameter less than 0. 45 micron, ·75% less than O. 90 micron, and 90% less
than 1. 60 microns.
2.

Gastrointestinal Tract

Lead is present in all classes

of natural foods and water and the

average daily intake from the diet is about 0. 3 mg pe.r day with a range
between 0.1 and 2. 0 mg (Kehoe, 1961).

Only 10% of the ingested lead is·

absorbed (Kehoe, 1961) and this absorption occurs mainly from the small
intestine, to a lesser extent .from the colon, and not at all from the stomach
(Harvey, 1965).

The major part of the absorbed lead enters the entero-

hepatic circulation and only a small portion ever reaches the systemic
circulation (Cantarow and Trumper, 1944).

Thus, even though 90% of the

total lead intake is contributed by the diet, the respiratory tract, under
normal conditions, is the most important portal of entry of lead.
Kehoe et al. (1943) have shown that none of the variations in milk, calcium, phosphorus, pectin, or ascorbic acid intake affect the absorption of
lead.

The only factor found to significantly influence this absorption was

~

------------------------------------------------------------__,j~
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the motor activity of the bowel.

A decrease in the number of evacuations

caused an increased absorption of lead, while an increase in frequency
caused a decreased absorption.
3.

Skin

Absorption of inorganic lead compounds through the intact skin is of
little significance -in the development of lead poisoning (Legge and Goadby,
1912; Hamilton, 1912; Oliver, 1914):

H.owever, lead salts can be absorbed.

through abrasions and numerous cases of lead poisoning have heen reported
to occur following the application of lead containing lotions_ and ointments to .
ulcers, burns,· ·skin ·eruptions, and areas -of inflammation (Tanquerel des
Planches, 1839).

Plumbism has also been reported to occur from the ab-

sorption of lead from bullets lodged in tissues (Oliver; 1914; Machle, 1940).
Organic lead compounds such as tetraethyl lead (TEL) have been
shown to pass readily through intact skin.

Kehoe _and

Tham~nn

in 1931

demonstrated that pure TEL is rapidly absorbed when applied to the skin
of rabbits.

However, TEL absorption from gasoline containing 0.1% TEL

was found to be inappreciable.

Since TEL-is eventually converted in the

body to inorganic lead, continued absorption of small amounts of TEL ·
can result in the classical syndrome of chroniclead intoxication ..
C.

TRANSPORTATION OF LEAD IN THE BODY

r.~·---------------~
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Once lead is absorbed, it is transported by the blood in which 90 to
95% is bound to the red blood cells (Blumberg and Scott, 1935; Cantarow
and Trumper, 1944; Stover, 1959).

The form in which it is carried is

believed to be either as an albuminate (Oliver, 1914), a dibasic phosphate in
colloidal form (Aub et al. 1925), or a diphosphoglycerate (Maxwell and
Bischoff, 1929).

Witsc:bi (1965) has recently found that lead is bound at least

partly to the deeper layers of the plasma protein film on the erythrocytic
surface.
The normal range of lead levels in blood is 15 to 40

pg per 100 ml

(Goldwater and Hoover, 1967) with the upper limit of normal being 60 to 80

pg per 100 ml. Kehoe (1964b} stated that when the lead concentration in the
blood reaches or exceeds the level of 80 pg per 100 g, the individual has
absorbed a potentially-dangerous quantity of lead.

Several investigators,

however, believe that a blood lead level of only 60 pg per 100 ml is
indicative of an excessive lead absorption (Berman, 1966; Cramer et al.,
1966; Weber, 1966}.
D.

DEPOSITION OF LEAD IN THE BODY
Lead present in the general circulation is at first distributed to the

kidneys, liver,. lungs, spleen, and muscle.

However, within a few days,

the lead is re-distributed to the bones where it is deposited as an insoluble
tertiary lead phosphate (Aub et al., 1925).

Normal individuals have a

~--------------------~
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higher concentration of lead in the long bones than in the flat bones, however, in cases of lead poisoning the reverse has been found to be true
(Kehoe, 1961).

Growing bones have the highest concentration of lead in

the epiphyseal portion of the long bones and "lead deposits may be detected
·•
·by X-ray examination as rings of increased density in the ossification.
centers of the epiphyseal cartilage and as a series of transverse lines in
the diaphyses" (Harvey, 1965}.

These findings are of diagnostic importance

in the determination of lead poisoning in children.
Bolanowski et al. (1964) using adult male albino rats injected with a
single dose of Pb

210

divided the organs into three basic compartments

differing in lead exchange rates.

The first is the rapid exchange pool

consisting of blood, heart, lungs, liver, kidneys, spleen, and GI tract.
The second compartment is the intermediate pool consisting of the muscles
and skin and the third is the slow exchange pool including bone and
whole tail.
Factors affecting the metabolism of calcium similarly affect the
metabolism .of lead (Harvey, 1965).
.

"High phosphate intake favors

skeletal storage of lead. and a lowering of the lead content in soft tissues.
A high calcium intake in the absence of an elevated phosphate intake

11
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causes a mobilization of lead from the bone due to competition with lead
for the available phosphate.

"Vitamin D tends to promote the deposition

of lead in bone provided a sufficient amount of phosphate is available.
parathyroid hormone mobilizes lead from the skeleton and elevates the
blood level and urinary excretion. " Acidosis promotes the mobilization of

•
lead-from bone as do iodides and bicarbonate.

The body of an average 80 kg human has been reported to contain
100 to 400 mg of lead (Kehoe, 1961).

The concentration of lead found in the

brain, lung, heart, liver, spleen, kidney, muscle, flat bone, and long
bone expressed as mean lead mg per 100 g of tissue is 0. 04,

c(.cfa,

O. 04,

0.12, 0. 03, 0. 05, 0. 03, 0. 65, and 1. 78, res-pectively.
E.

EXCRETION OF LEAD

The total intake of lead due to food, beverages, and air approximates
O. 33 mg per day (Kehoe, 1964a).

Of this amount, 0. 3 mg per day is

eliminated in the feces and 0. 03 mg per day is eliminated in the urine.
The amount present" in the feces consists largely of the lead that had
passed through the GI tract without being absorbed, while the amount
in the urine reflects that amount that was absorbed and is present in the
blood.

The normal individual has a urinary lead content of 20 to 65 )lg

,,.---------------------------------------------------------,
9

per liter with an average of 35 (Goldwater and Hoover, 1967).

The upper

limit of normal has been stated to be 150 pg of lead per liter of urine
(Kehoe, 1964b).
F.

LEAD INTOXICATION

The accumulation of large amounts of body lead constitutes an
important health hazard with regard to both children and adults.

Lead

poisoning in children is often the result of oral ingestion of chips of leadcontaining paint, while lead poisoning in adults usually results from
accidental exposure to lead in an industrial environment.
1.

Signs and Symptoms
a.

A cute lead intoxication

"Acute lead poisoning is quite rare and occurs following the
accidental ingestion of lead compounds that dissolve readily in the stomach
contents" (Harvey, 1965).

The symptoms are a sweet metallic taste,

thirst, nausea, vomiting, abdominal pain, and diarrhea or constipation.
A cute nervous system symptoms including parasthesias, pain and

muscle weakness occur and kidney damage and urinary changes are evident.
The shock syndrome may develop and acute hemolytic anemia may be
present.

Death usually results within 1 to 2 days.

I
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b.

Chronic lead intoxication

The major clinical features of adult lead intoxication are abdominal
pain, constipation, vomiting, nonabdominal pain, muscle weakness,
and parasthesia (Dagg et al., 1965).

Abdominal pain is the most prevalent

complaint and in Dagg's study occurred in 90% of the patients with lead
poisoning.

Anemia, stippled erythrocytes,

l~ad

line on the gums, and

reticulocytosis are also commonly seen in lead-intoxicated patients.
Anemia was noted in over 90% of the

patients~

while stippled red cells

were present in 76%.
In children, the microcytic hypochromic anemia associated with
chronic lead intoxication is often more pronounced than that seen in
adults and i$ oftep
(Watson et al.,

ac~ompanied

195~U.

with abnormallylow serum

i~on leve~s

Often, the pallor due to anemia is the only sign

or symptom seen in children with- chronic lead poisoning ... As in adults,
children demonstrate GI disturbances, anorexia, vomiting, and
constipation.
nerv~us

Children, however, usually develop more severe central

system

complica~ions

including encephilitis and mental retardation ..

Chisolm Jr. (196!5) has stated that the sericms sequelae of lead intoxication
during early childhood are mental retardation, behavior disturbances,
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convulsive disorders, and nephropathy.
i.

Stippled erythrocytes

Behrend in 1899 was the first to report that lead causes stippling of
the erythrocyte. 'Today, we recognize that two different types of granulations may be present in the erythrocytes of lead-intoxicated patients
and -animals (-Griggs, 1964).

The first type of granulation is due to an

accumulation of excessive iron urn.:1.sable for hemoglobin formation and
the second type represents damaged mitochondria that do not contain
iron.
The spleen is thought to play an important role in regulating the
number of stippled erythrocytes in the general circulation.

Stippled

erythrocytes are young cells (Baikie and Valtis, 1954) and Bessis and
Breton-Gorius (1962) have suggested that the spleen removes these cells
from the circulation and causes removal of the granules either by maturing
the cell through some unknown mechanism or by a process similar
to that seen for the removal of siderocytic granules from red blood
cells.
ii.

Erythrocytic fragility

The erythrocytes from patients with lead poisoning often demonstrate
increased resistance to osmotic lysis and increased susceptibility to
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mechanical trauma (Griggs, 1964). Aub et al. (1925) produced similar
effects in vitro by incubating normal red blood cells with lead.

Harris

and Greenberg (1954) also demonstrated that the addition of lead chloride
to normal human red blood cells suspended in autologous serum or
isotonic saline is followed by an increase in the mechanical fragility of
the cells and a decrease in susceptibility to osmotic lysis.

Waldron (1964),

however, found that red blood cells incubated with lead have only a
slightly greater mechanical fragility index than controls.
Changes in osmotic and mechanical fragility indicate alterations in
the morphology and permeability of the erythrocytic membrane.

Min

(1964) has reported that lead chloride induced a loss of potassium from
rabbit erythrocytes and Hasan et al. (1967a) have found that the erythrocytes from lead-exposed workers have an enhanced potassium loss.

The

activity of the /Na+ +K+ I -ATPase present in the membranes of the red
blood cells from lead-exposed individuals has been reported to be
decreased (Hasan et al., 1967b) and this finding is consistent with an
accelerated loss of intracellular potassium since /Na+ +K+

I -ATPase is

closely associated with active ion transport.
The red blood cell's increased resistance to osmotic lysis seen in
both the in vivo and in vitro experiments indicates that a greater amount
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of water could enter the cell before lysis occurs.

The decrease in mean

corpuscular volume, the increase in specific gravity, and the increase in
mean corpuscular hemoglobin concentration

indicate that "leaded" cells

are shrunken and therefore have a greater capacity for swelling in hypotonic
solutions.
iii.

Erythrocyte survival

Hernberg {1967) has reported that workers exposed to lead for a
mean of six years have a 20% shorter red cell survival time than nonexposed workers and this difference was found to be highly significant.
Sheets et al. {1951), using the Ashby technique, studied the red cell
survival time from a patient with lead poisoning and found that 50% of
the cells had d_isappeared in approximately 25 days, compared to a normal
50% survival time of 55 to 60 days.

Rubino et al. (1958), Crepet et al.

(1963), and Griggs {1964) have also reported shortened red blood cell
survival times in lead-poisoned adults.

Leikin and Eng (1963) have likewise

shown that children with chronic lead poisoning have shortened red cell
survival times.

Those children having a relatively short history of

lead intoxication demonstrated the most pronounced shortening.
iv.

Anemia

The precise cause of lead induced anemia is not known at present.
Aub et al. {1925) concluded that the anemia was hemolytic and this view was

~
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supported by the work of McFadzean and Davis (1949) and by Pirrie (1952).
These latter two groups of investigators demonstrated that the anemia
which developed in lead-poisoned animals was rapid in onset and was relieved by splenectomy.

More recently Crepet et al. (1963) have reported

that the anemia is produced by hyperhemolysis and by defective hemoglobin
formation and these factors may act together or individually.

Waldron (1966)

also stated that the anemia of lead· poisoning is due to the effect of lead on the
enzymes responsible for heme synthesis .

Gajdos et al. (1964) defined the

anemia induced in experimental lead poisoning as being due to (1) inhibition
of heme synthetase, the enzyme that catalyses incorporation of iron into
protoporphyrin, (2) inhibition of erythropoiesis, and (3) partial hemols:sis of
the red blood cells which shortens their survival time.

Inhibition of heme

synthetase by lead has also been reported by deBruin and Hoolboom (1967).
v.

Encephalopathy in children

The infantile brain is extremely susceptible to the toxic effects of lea
and it is common for lead-poisoned children to develop restlessness,
irritability, and convulsions.

Once encephalopathy occurs, there is a case

fatality rate of almost 25% with more than 50% of the survivors having
damage to the central nervous system (Smith et al., 1965).
Okazaki et al. (1963) using the brains from lead-poisoned children
found that the hippocampal and frontal cortices contained the highest lead
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levels, while the occipital white matter and pons had the lowest levels.
These investigators suggested that the initial effects of lead poisoning were
selectively exerted upon the small caliber blood vessels in the brain
causing increased permeability, focal necrosis; occlusion, and the transudation of plasma fluid into the perivascular, interstitial and subpial spaces.
Pentschew (1965) reported that the brains from lead-poisoned children
had dilated capillaries with swollen endothelial nuclei protruding into the
lumen and microglial nodules spreading out over various gray areas and
also over the white matter.

The molecular layer of the cerebellar cortex

contained loose accumulations of microglia cells and this layer was found
to suffer the greatest damage in lead encephalopathy.

The underlying

cause of lead encephalopathy was considered to be a toxic disorder of
porphyrin synthesis which resulted in a chronic metabolic hypoxidosis.
vi.

Effect of lead on the germ cells

Constantin Paul in 1860 was the first to allege that lead might injure
the male germ cell.

Based upon his observations of clinical cases, he

reported that lead poisoning of either the mother or father often caused
stillbirth and that the infant mortality of children born of such parents was
particularly high during the first three years of life.
Meillere (1903), Baader (1928), and Fraenkel (1905) have shown that
lead-exposed workers have dimini.shed sperm motility, testicular atrophy. and
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diminished spermatogenesis.

Koinuma (1926) compared the marital life

records of workers exposed to lead in Japanese storage battery plants with
the histories of those working in nonlead occupations and reported that
infertile marriages constituted 24. 7% for the lead group as opposed to only
14. 8% for the nonlead group.

The percentage of pregnancies ending pre-

maturely or in stillbirth was 8. 2% for the lead and O. 2% _for the control group
Additional evidence that lead can inj.ure the male germ cell was supplied
by Weller (1915-16, 1916-17) when he demonstrated that the offspring of
lead-poisoned male guinea pigs were underweight and weak.

The "leaded"

males were usually not sterile, but when.mated with a normal female the
weight of their young was_ 18. 5% below normal.

Similar results have also

been reported using rabbits and fowl (Col.e and Bachuber, 1914). Puhac et al.
(1963) fed male rats lead nitrate for 30 days and found that when they were
paired with untreated females no reproduction took place for 45 days.
In women lead is an active abortifacient and an increased frequency of
miscarriages, stillbirths, and premature births in female lead workers has
been recognized for years.

Lead-exposed women may experience transi-

tory periods of sterility with subsequent occurrence of normal pregnancy
after withdrawl from exposure and this indicates that lead injures only the
germ cells formed during the period of intoxication and that the damage to
the gonads is not permanent (Paul, 1860).

Women who have had several

-
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miscarriages and stillbirths during periods of lead exposure may subsequently have normal pregnancy after cessation of exposure.

If living

children are born to women with lead intoxication, they usually are smaller.
weaker. slower in development. and have a higher infant mortality (Legge
and Goodbody, 1912; Aub et al., 1925) and similar observations have been
made in dogs, cats, rabbits, guinea pigs, and fowl.

These phenomena have

been attributed to (a) placental injury and hemorrhage, (b) degenerative
changes in the chorionic epithelium, (c) spasm of the uterine

muscl~.

and

(d) direct action of lead on the fetal tissue (Cantarow and Trumper, 1944).
Lead-poisoned female rabbits have shown alterations of the chorion
resulting in the death of the embryo and Hamilton (Cited by Moeschlin, 1965)
reported that women abort due to lesions of the chorion epithelium or of the
fetus itself.

Bell (1924) from his studies on the action of lead on malignant

cells concluded that lead acts directly on the embryonic cells of the chorion
·epithelium causing degeneration.

Since lead passes from the maternal

circulation to the fetus and has been found in all.of the fetal organs
(Cantarow and Trµmper, 1944); it is also possible to speculate that intrauterine death and abortion are caused by the direct toxic action of lead on
fetal tissues.

Bell (1924) found that lead inhibits the growth of embryonal

and other growing tissues and concluded that the arrest of growth in animal
organisms is strictly proportional to the capacity for, or power of, growth.
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The fact that children born of mothers with lead poisoning develop more
slowly than normal and have a higher mortality during the first year of
life indicates that intrauterine exposure to lead has damaging effects.
vii.

Lead nephropathy

Damage of the kidney has long been associated with lead poisoning
and the nature of damage depends upon the type of intoxication {Albahary
et al., 1965).

Tubular involveme·nt
is dominant
in the
acute form,
while
..
--..
·

.'

diffuse changes occur after prolonged exposure.
nephrosclerosis develops as
-

a result of damage" to the" renal vessels.
.-

-

-.

In chronic lead poisoning,

--

.

-

.

..

Oliguria, albuminuria, and cylinduria have been reported to occur in
lead:-exposed workers (Legge and Goadby, 1912; Oliver, 1914). Dreessen et
al.- (1941) found that albuminuria 0ccurs twice as frequently in lead-exposed
workers with other evidence of lead intoxication as in nonaffected workers"
-·
. -or in workers in other industries, the incidence and severity of albuminuria
increasing with duration of exposure and increasing· concentrations of lead i
-

the air to which the subjects were exposed.

-

Following the intravenous in-

Jection of collo~dal lead preparations to_ human subject_s, Bell et al. (1925)
observed oliguria, albuminuria, and edema, with marked degenerative
. changes in the renal tubular epitheiium: Cases of lead intoxicatfori have also
been reported with glycosuria, aminoaciduria (Wilson et al., 1953) and hyper
phosphaturia (Chisolm

Jr~

et al., 1955; Chisolm Jr. and Leahy, 1962).

~
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The renal tubular cell linings of rats fed a 1% lead acetate diet were
found to contain intranuclear inclusions after eight weeks on the diet, cytoplasmic vacuoles after one week, and swollen mitochondria with disrupted
cristae after three weeks (Goyer et al., 1965).

Galle and Morel-Maroger

(1965) reported that in both man and rats lead selectively affects the proximal tubular cells and produces intranuclear inclusions,. iron containing
intracytoplasmic inclusions, and marked mitochondrial lesions.

Intranuclear

acidophilic inclusion bodies were also found by Blackman (1936} in the renal
tubular epithelium of 21 children with lead encephalopathy.

Some of the af-

fected cells were enlarged, others flattened and basophiHc in app.earance,
some contained fat and some were necrotic.

Some of the tubules were atro-

phied and there was also evidence of mild chronic inflammation and fibrosis.
Henderson (1954) has reported follow up studies on children in Qu.eens ...
land, Australia who had acquired lead poisoning from the ingestion of
powdered white lead paint.

He noted that many of these children died later

in life due to chronic nephritis, ahd of the 127 who could be located alive,
17 had hypertension and albuminuria.

Studies by Croll (1929), Nye (1933),

and Murray (1939) have shown that chronic renal disease was unusually
frequent in persons under forty years of age in Queensland.

This high

incidence was related to the occurrence of lead poisoning in infancy and
early childhood due to the ingestion of paint from the veranda railings of the
homes. Nye has concluded that every child who has had lead poisoning is a
.·.·.
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potential subject for chronic renal disease later in life.
2.

Heme Biosynthesis
a.

Normal heme biosynthesis

The biosynthetic sequence of heme has been elucidated as a result of
the research conducted mainly in the laboratories of Shemin and Granick in
the United States and Neuberger and Rimington in Great Britain.

As early

, as 1948 it was found that avian red blood cells can synthesize heme in vitro
(Shemin et al., 1948) and soon after, cell free extracts of duck erythrocytes
were found to accomplish heme synthesis from the proper substrates (Shemin et al., 1955).

When chicken cells, rabbit reticulocytes, or human red

cells from er-ythroblastosis fetalis are hemolyzed,. a number of the enzymes
of the heme biosynthetic pathway are found to be soluble and can be separated
from each other by zone electrophoresis on starch (Granick and Mauzerall,
1958).

These soluble enzymes are localized in the cytoplasm and include

delta-aminolevulinic acid (ALA) dehydrase, porphobilinogen (PBG) deaminase, uroporphyrinogen (UPG) isomerase, and uroporphyrinogen decarboxylase.

The insoluble enzymes are localized in the mitochondria and include

ALA synthetase, coproporphyrinogen (CPG) oxidase, and heme synthetase
(Sano and Granick, 1961).
The first step in heme synthesis is tl:c condensation of succinyl CoA
with glycine (Shemin et al., 1955; Gibson et al., 1958; Kikuchi et al., 1958)
to form o<. -amino-8-keto adipic acid which readily decarboxylates yielding
delta-aminolevulinic acid (Shemin et al.,' 1955; Neuberger, 1961).

This
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reaction is catalyzed by the enzyme ALA synthetase and requires pyridoxal

phosphate as a co-factor (Lascelles, 1957; Schulman and Richert, 1957;
Kikuchi et al., 1958).

The enzyme ALA dehydrase condenses two molecules
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of ALA forming one molecule of porphobilinogen and water (Gibson et al.,
1955).

Three molecules of porphobilinogen then combine under the influence

of PBG deaminase to form tripyrryl methane and this in the presence of
UPG isomerase and PBG is converted to uroporphyrinogen III (Bogorad, ·
1958a, b; Cornford, 1964).

The four acetic acid side chains of uroporphyrin-

ogen III are then decarboxylated by UPG decarboxylase to produce coproporphyrinogen III (Mauzerall and Granick, 1958).

Two propionic acid side

chains of coproporphyrinogen III are oxidatively decarboxylated to form vinyl
groups by CPG oxidase and this results in the formation of protoporphyrinogen IX (Sano and Granick, 19 61). . Protoporphyrinogen IX is then autooxidized
to form protoporphyrin IX (Sano and Granick, 1961) and heme synthetase
inserts one ferrous ion into each molecule of protoporphyrin IX forming
heme (Goldberg et al., 1956; Labbe and Hubbard, 1960).
Shemin (1957) demonstrated that labelled glycine, when fed to humans,
was incorporated into the heme of newly formed erythrocytes and this led
to the finding that glycine and succinyl CoA are the elementary building
blocks of heme.

Most of the succinyl CoA required for condensation with

glycine originates from the oxidation of ...(-ketoglutarate through the
operation of the tricarboxylic acid cycle, ::i.lthough some is generated from
succinate and CoA in the presence of a nucleoside triphosphate by the enzyme
.succinyl CoA synthetase (Brown, 1958; Shemin and Kumin, 1952).

The
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mitochondria seem to be the principal site of ALA synthesis because
succinyl CoA is formed via oL.. -ketoglutarate oxidase which is a mitochondrial enzyme complex and because ALA synthetase is present in
mitochondria.

As the mitochondria degenerate in maturing red blood

cells, the ability to synthesize ALA decreases and in mature erythrocytes
only the enzyme

a.ctivitie~

that convert ALA to coproporphyrinogen can

be detected (Granick and Levere, 1964).
b.

Effect of lead on heme synthesis

Lead has been found to exert an inhibitory effect on several of the
enzymes necessary for heme synthesis e.g. ALA dehydrase,. CPG
oxidase, and heme synthetase.

ALA dehydrase (Gibson et al., 1955)

and heme synthetase (Schwartz et al., 1959) both contain essential
sulfhydryl groups and a blockage of such groups by lead may be the cause
of the inhibition of their activity.
i.

A LA dehydrase

Several authors have reported that the activity of this enzyme is
decreased in erythrocytes from lead-intoxicated patients (Lichtman and
Feldman, 1963; Bonsignore, 1966; deBruin and Hoolboom, 1967).

Bonsignor

et al., (1965a) injected rabbits subcutaneously with lead acetate and found
that the activity of A LA dehydrase in the blood was decreased 1 hour after
injection.

The activity returned to normal between the first and sixth day
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after injection, hut then decreased again and remained low to the twentieth
day when further observations were discontinued.

In man, A LA dehydrase

has been found to remain inhibited for up to three years after cessation of
lead exposure (Saita and Moreo, 1964).
Bons_ignore et al. (1965b) have found that the inhibitiorl: of the enzyme
A LA dehydrase is competitive and can partially be removed by administer-

ing sulfhydryl compounds as cysteine and glutathione.

By using in vitro

techniques, a maximum reactivation of 60% of the ALA dehydrase inhibited
5
by a solution of 10- M lead acetate was produced by cysteine in a concentration of 2. 5 x 10- 2 M.
- ii.

CPG oxidase

An increased urinary excretion of coproporphyrin from individuals

with lead intoxication has been known for years.

Coproporphyrinogen III is

the compound that is excreted in the urine, however, it is rapidly oxidized
to coproporphyrin III (Watson et al. , 1951; Weatherall, 1952).

The increased

urinary excretion of coproporphyrin III in lead poisoning has been postulated
to be due to destruction in the bone marrow of young red blood cells containing large amounts of coproporphyrinogen III (Schmid et al., 1950).

This

increased amount of coproporphyrinogen III in the young red blood cells is a
result of the inhibition of the enzyme CPG oxidase by lead.
iii.

Heme synthetase
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Erythrocyte protoporphyrin IX levels have been found by Rubino et al.
(1958) to be elevated in 21 of 22 patients with lead poisoning.

Increased

amounts of protoporphyrin IX in the erythrocytes of lead poisoned patients
have also been found by Vigliani and Waldenstrom (1937).

Whitaker

~nd

Vietti (1958) have shown that children with lead intoxication also have
increased amounts of protoporphyrin IX in the erythrocytes.

Lead inhibits

the in vitro synthesis of heme from protoporphyrin IX and iron of chicken,
rabbit, and human erythrocytes (Rimington, 1951; Jandl et al., 1959) and it
has been reported that in humans, elevated levels of protoporphyrin IX
persist in the erythrocytes up to nine years after cessation of lead exposure
(Saita and Moreo, 1964).
3.

Treatment
a.

A cute lead poisoning

Gastric lav'age with a 3% sodium sulfate solution combined with ample
amounts of animal charcoal should be administered immediately.

This

converts the soluble lead into the slightly soluble lead sulfate and causes
adsorption of the lead to the charcoal.

Magnesium sulfate can be given as

a cathartic in order to rush the ingested lead through the intestinal tract
with as little absorption as possible.

Calcium disodiurn edetate (CaNa2

EDTA) is then administered.
b.

Chronic lead poisoning
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i.

Specific therapy

Dimercaprol (2, 3-dimercaptopropanol) has been reported to be
effective in the treatment of chronic lead poisoning (Ryder and Kehoe, 1947;
Harvey, 1965; Moeschlin, 1965).

Even though it initially causes an

increased urinary excretion of lead, this effect is temporary and the amount
of lead actually mobilized is negligible.

It appears that dimercaprol is only

able to chelate the lead in blood and that "lead in bone and soft tissue is too
firmly boun« to be mobilized. "
Calcium disodium edetate, an ion exchanger, was discovered in 1953
to be effective in the treatment of lead intoxication (Rubin et al., 1953) and
is now the drug of choice.

Lead displaces calcium from the calcium

disodium edetate and forms a water-soluble lead chelate which is eliminated
by the kidneys.

Several investigators havE:: reported that lead excretion

increases up to ten fold after initiation of calcium disodium edetate therapy
(Hernberg and Laamanen, 1964; Westerman et al., 1965; Selander, 1967).
The use of calcium disodium edetate, however, has certain disadvantages among which are its nephrotoxicity (Foreman .et al., 1956; Vogt
and Cottier, 1957); and the necessity of it being administered intravenously
to obtain maximal efficiency.
sodium edetate vary.

Opinions on the efficacy of oral calcium di-

Some authors maintain that it is effective (Manville

and Moser, 1955; Bell et al., 1956), whereas others consider oral administration
to be contraindicated because it increases the absorption of lead from the gut and
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may precipitate or increase the symptoms of poisoning (Kehoe, 1955; Byers,
1959).

Selander (1967) reported that oral calcium disodium edetate was not

effectiye in causing an increased lead excretion and stated that this was due
to its poor absorption from the gastrointestinal tract.
Penicillamine administered orally has been shown to be effective in
the treatment of lead poisoning (Boulding and Baker, 19S.7; Ohlsson, 1962;
Selander et al., 1966).

Calcium disoqium edetate is preferable in the

treatment of severe cases of lead intoxication due to its ability to mobilize
2 to 8

~imes

more urinary lead than penicillamine (Gaultier et al., 1966).

However, penicillamine's use in the treatment of lead intoxication is assure
because of its effectiveness when given orally and its less severe side effect
Penicillamine has also been recommended as a prophylactic agent against
lead poisoning (Albahary and Guillaume; 1966).
ii.

Spasmolytics

Chlorpromazine, papaverine, extract of belladonna, and calcium
gluconate are the most effective drugs for the treatment of lead colic
(Moeschlin, 1965).

Hot compresses and hot baths may also help relieve

the cramps associated with the colic.
iii.

Sedatives

Chlorpromazine and various forms of barbiturates are used for the
treatment of excitement, mania, and convulsions.

Pentothal-sodium
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administered intravenously is used for the treatment of lead encephalopathy.
iv.

Puriatives

Kehoe (1943) has found that the motor activity of the bowel influences
the absorption of lead.

A decrease in the number of evacuations causes an

increased absorption of lead, while an increase in the frequency causes a
decreased absorption. Sodium sulfate is the drug of choice for causing
regular evacuation of the bowel (Moeschlin, 1965).
4.

Laboratory Tests Used for the Early Detection of

Increased Lead Exposure
a.

Number of basophilic stippled cells in peripheral blood

As mentioned previously, there usually is an increased number of
stippled erythrocytes in the peripheral blood of lead-exposed individuals.
Stippling, however, is generally considered an unreliable criterion of lead
intoxication because it also occurs in a large number of blood diseases such
as various types of hemolytic anemia, post hemorrhagic anemia, leukemia,
and after exposure to benzene, aniline, carbon monoxide, arsenic, copper,
and bismuth (Haeger-Aronsen, 1960). The upper limit of normal is approximate and the values cited vary considerably, ranging from 1 per 10, 000 RBC
(Schmidt, 1919} to 90 per 10, 000 (Sanders, 1943).
b.

Determination of coproporphyrin III in the urine
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Coproporphyrin III excretion in the urine has been shown to be elevated
in lead poisoning (Wyllie, 1955; Holecek, 1957; Benson and Chisolm. 1960;
Haeger-Aronsen, 1960). However, coproporphyrin levels are also increased
in various forms of anemia, particularly hemolytic anemias. in jaundice
whether due to diffuse liver damage or to biliary obstruction. in some
infectious diseases such as pneumonia and acute poliomyelitis, and in
several types of intoxication including mercury. bismuth.

sulfon~l.

and

sulfonamide poisoning (Haeger-Arons en. 1960). The upper limit' of :normal
for urinary coproporphyrin is 15 pg per 100 ml of urine~
c.

Determination of the concentration of.lead in hair

Kopito et al. (1967) have recently described a procedure for the analysi
of lead in hair.

This

procedu~e

involves first segmenting the hair, then

washing each segment. and finally digesting the. washed segments in nitric
and perchloric acids.

The lead concentration of each segment is then

obtained by use of an atomic absorption spectrophotometer.
Using the procedure described above. Kopito et al. have shown that
patients with recent lead ingestion have a high lead concentration in hair
near the scalp, while patients with chronic lead ingestion have elevated
lead concentrations in all hair segments.

The lead levels in hair were

reported to have a good correlation with the radiographic findings of
increased bone density and with other laboratory findings.
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'I'he laboratory procedures used for determining the concentration of
lead in hair, however, are time consuming and require skilled laboratory
assistants.

Therefore, the practicality of using lead in hair as a screening

test for early detection of increased lead absorption is questionable.

This

procedure is also not suitable for diagnosing acute cases of lead intoxication
Still another limitation for the use of this method is the fact that the hair of
Negro children grows at a very slow rate

and this makes it extremely

difficult to separate their hair into enough segments· for the performance of
a proper lead analysis.
d.

. Determination of lead in blood and urine

Most investigators. agree that an increased level of lead in .the blood.
and urine is the most specific sign of increased lead absorbance.
be remembered, however, that the blood is rapidly

cle~red

It m.u$t

of lead and

blood lead levels are considered of value only in acute cases of lead intoxication.

Berman {1966) has reported that the blood lead levels in chronic

cases of lead poisoning are not remarkable.
'!'he drawing of blood samples and the analytical procedures for
determining the lead levels in blood and urine are time consuming processes
requiring skilled per-sonnel and it therefore appears that the determination
of lead in the blood and urine is not practical as a screening test for early
detection of increased lead absorption.
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e.

Determination of delta-aminolevulinic acid (ALA) in

the urine
Mauzerall and Granick in 1956 developed a sensitive colorimetric
method for the quantitative determination of urinary ALA.

Using this

method, a 1. 0 ml aliquot of urine (pH 5 to 7) containing porphobilinogen,
urea, and A LA is placed on a column of Dowex 2 resin in the acetate form.
The column is washed with two 2 ml portions of water and porphobilinogen
is retained on the Dow ex 2 column, while urea and A LA are washed off.
The washings from the first column are then passed through a column of
Dowex 50 resin in the acid form.

This Dowex 50 column containing ALA

and urea is then washed with 16 ml of water to remove the urea.

A 3 ml

aliquot of 0. 5 M sodium acetate is added to the column and after draining,
the ALA is eluted from the column by the addition of 7 ml of O. 5 M sodium
acetate.

This eluate is collected in a 10 ml volumetric flask, 0. 2 ml of

acetylacetone is added, and the solution is diluted to the 10 ml mark with
acetate buffer at pH 4. 6.

The flask is stoppered and is placed in boiling

water for 10 minutes, then cooled to room temperature.

To a 2. 0 ml

aliquot of this solution is added 2. 0 ml of modified Ehrlich's reagent.
The resulting solution is mixed and after 15 minutes its optical density
at 553 mp is read against a blank.

The blank consists of water treated

in the same manner as the Dowex 50 eluate.

~·
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Haeger in 1957 using Mauzerall and Granick's technique, reported
that workers exposed to inorganic lead have considerably elevated ALA
levels in urine.

Since then, numerous other investigators have shown

elevated urinary ALA levels in cases of clinical adult plumbism and in
adult workers exposed to lead (Haeger-Aronsen; 1960; de Kretzer and
Waldron, 1963; Kleinstein et al., 1963; Efe, 1964; Cramer and Selander,
1965; Cramer et al., 1966; deBruin and Hoolboom, 1967).
Bonsignore et al. (19 65) and deBruin and Hoolboom (1967) have
demonstrated an ·early decrease .in the activity of ALA· dehydrase in the
blood of both adult workers and rabbits exposed tq lead and it appears
likely that the accumulation of A LA in the urine of individuals exposed

~o.

lead is due to an irihibition of the ALA dehydra.se loca;tedin red_bloocl ..·- __
cells.

Additional evidence that the increased excretion of ALA is due

to an inhibition of A LA dehydrase rather than a stimulation of ALA.···
synthetase has been supplied by Gajdos and Gajdos-Torok (1964) and
by Pecora et al. (1964).

These investigators studied the activity of

ALA synthetase in mitochondria isolated from hepatic tissue of lead.
.
.
poisoned rabbits, guinea pigs, and rats and reported that the activity of
this enzyme was not measureable in the lead-poisoned animals nor in
the controls.

Rimington (1961) has shown that the livers of both lead-

poisoned and control rabbits have similar ALA contents.
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Urinary ALA levels have been reported to have a positive correlation
with blood lead levels {Selander et al., 1966), urinary lead excretion
(Haeger-Aronsen, 1960; Cramer and Selander, 1965), and clinical
impression of lead intoxication (Cramer and Selander, 1965).

Raised

ALA levels in the urine have also been found to be closely correlated
to raised ALA levels in serum {Saita and Moreo, 1961; Chiesura and
Brugnone, 1963).

Blood and urinary ALA levels remain significantly

increased for up to

thr~e

years after cessation of lead exposure (Saita

and Moreo, 1964).
Ari increased ALA excretion has been reported

to be an earlier

sign of lead exposure than an increased. coproporphyrin excretion (Singerman, 1964; Djuric et al., 1966) and several investigators have stated
that an increased ALA excretion is the earliest sign of an increased
lead absorbance (Efe, 1964; Djuric et al., 1966).

An i:r:icreased u.rinary

A LA level also appears to be pathognomonic of elevated lead absorption
since the only other conditions known to result in an increased ALA
excretion are acute intermittent porphyria and certain liver diseases.
Haeger-Aronsen (1960) determined the urinary ALA
content of patients
-- ...
'

.

-

with either biliary disease, acute hepatitis, cirrhosis of the liver,

,,. ----------------------------------------------------------------.
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hemolytic anemia, pernicious anemia, malignant tumor, leukemia,
diabetes mellitus, nephropathy, or drug intoxication.

The concentration

of ALA in the urine was normal in all cases except three.

Two of these

were patients with acute hepatitis and one was a man with bronchial
cancer.

Schlenker et al. (1964) determined the urinary ALA content

of patients with Hodgkin's disease, cirrhosis, leukemia, multiple
myeloma, sickle celL anemia, or cancer and the only patient showing
an elevated urinary ALA. level was
.

.

~he

one_ with cirrhosis .. Griggs
~

~

.

-··

(1964) compared the urinary ALA levels of patients with lead toxicity,
acute intermittent porphyria, iron deficiency anemia, hemolytic anemia, .
pernicious anemia,·· or liver disease· and· found that elevated levels are ·
seen only in patients with lead poisoning, acute: intermittent

porphyria~

·and occasionally liver disease.
.

.

.

..

. .

.

I·

.·

..

Dantchev et al. (1964) have reported that adenosine-5-monophosphoric
acid (AMP) and inosine proteCt red blood cells against destruction by
lead.

Brugnone and Galzigna (1963) administered AMP to lead-poisoned

rabbits and obse_rved a decreased urinary excretion of ALA .. Leadpoisoned rabbits were also treated with AMP plus pyridoxal phosphate and
the decrease in urinary ALA excretion from these animals was more pro-

,,,.____________________________________,
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nounced than

fro~

those treated with AMP alone.

The ALA in the blood

was found to follow the same pattern as the urinary ALA.

Koziolowa-

Lipska and Gutniakowa (1966) administered AMP to patients with chronic
lead poisoning but could not demonstrate any significant
decrease in
.
.

.

urinary A LA excretion.
Haeger-Aronsen (1960) studied the influence of temper9.ture, pH,·
calcium disodinm edetate,and penicillamin_e on the :3.tal?ility of ALA.in __
human
urine
and reported
that at ·- pH- levels
between . 4 and 7,- urine
can
.
...
.
.
.
.
-

. be ~torea at

.··

-

~.

'

+4°c in the da~k for at least th.ree weeks with~ut any

decrease in the concentration of_ALA.
of ALA was found to fall.

At a higher pH,

t~e

concentraHon

The concentration of-ALA in urine was found

to remain unchanged after the addition of either calcium disodium
edetate or penicillamine.

Bossenmaier and Cardinal (1968) also studied

the stability of ALA in human urine and reported that urine-having pH
levels between 1 and 9 can be stored at -20°c for at least four weeks
without any appreciable decrease in the concentration of ALA.

The

stability of ALA in frozen urine thus makes it possible to collect and
store large quantities of urine samples prior to the determination of
their ALA content and this would be a definite advantage if a screening
program using urinary A LA levels for the detection of early lead
exposure would be implemented.
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G.

PORPHYRIA

The porphyrias are metabolic disorders, mostly of hereditary nature,
characterized by an increased excretion of porphyrins and of their precursors.

In the erythropoietic porphyrias the porphyrins are elevated in the

bone marrow, while in the hepatic porphyrias they are mainly in the liver.

1.

- Erythropoietic Porphyrias a.

Congenital porphyria or Gunther's disease_

Congenital porphyria is a very rare

distur~ance.

which _i_s

c~aracterized

by a marked photosensitivity and an increased excretion of uroporphyrin and
~

--

-

coproporphyr!n~ predominantly of the uriphysiofogical s'-edes rtype (Goldberg
-

.

.

.

and Rimington, 1982).

.

.

.

--

.

.

--

This disease can exist in utero and individuals

possessing the genetic trait always develop symptoms before the age of six_
years.

The

bio~hemical

-

-

abnormality. appears to be lacking of uroporphyrino-=

gen isomerase from red blood cells owing to :a gene defe-ct and -because of thi
enzymic defect, series I porphyrins are released into the plasma and tissues
The photosen-sitivity associated with .this disease is a result of the presence
of these porphyrins in the epidermal layer of the skin.
b.

Erythropoietic protoporph-yria

This condition was first reported by Magnus et al. in 1961 and is
characterized by a mild photosensitivity arid by an increased fecal excretion
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37

of coproporphyin and protoporphyrin IX which are present in excess in the
circulating erythrocytes.

In contrast to findings in erythropoietic congenital

porphyria, there is no excess of uroporphyiin in blood or excreta.
2.

Hepatic Porphyrias
a.

Acute intermittent porphyria

This is the most important member of the group of porphyria diseases
and is characterized clinically by abdominal and neurological symptoms
which appear in acute attacks separated by latent phases (Goldberg and
Rimington, 1962). · In the acute· and latent phases bf this disea·se and often
in.st~tes of remission~ patientS' excrete in urine an excessive quantity

of.

porphob.tlinogen and ALA (Haeger, 1958).
This .disease occurs in members o.f t.he same family and Waldenstrom
in 1937 established it as a hereditary

diseas~.

The biochemical trait is.

transmitted as an autoso.nial dominant characterfstic (Goldberg andRimington, 1962) and the clinical manHestations are more frequent in females
Goldberg and Rimington (1962) described fifty cases of acute intermittent
porphyria and the most frequent age of onset was the third decade for
females and the fourth for males.

The youngest patient found was a girl

eleven years· of age.
The main symptoms of acute intermittent porphyria are abdominal
pain, vomiting, constipation, peripheral paralysis, and psychological
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disturbances and all these symptoms can be

account~d

for by the widespread

neurological lesions (Goldberg, 1959) which can involve the central, peripheral, and autonomic nervous systems (Gibson and Goldberg, 1956).

There

is an absence of skin photosensitivity because in this condition the porphyrin
precursors are the main excretory products. A possible mechanism for the increased quantity of ALA and porpho-

bilinogen eliminated in acute intermittent porphyria is that

~hereis
-

n,qrmally
-- -

-

a control or inhibitor of ALA synthesis in the liver, but this control breaks
down in the diseased subject:

Shemin (1960) found evidence for a neg.ative

feed-back control of in vitro ALA s·ynthesis by
Rhodopseudomonas spheroides.

prep~rations

derived_ from

In these_ preparations, AL.A was; found to be ·

inhibitory to the system producing it.

Granick (1965) stated that acute

intermittent porphyria results in part from an increased synthesis of A LA
synthetase due to a defective regulatory control mechanism governing the
activity of the structural gene which does not sufficiently repress the
formation of the enzyme.

Tschudy et al. (1965) and Nakao et al.(1966) have

recently reported that the Uvers from

patie~ts.

with acute intermittent

porphyria have an increased A LA synthetase activity .
.

b.

-

Hereditary coproporphyria

This rare disease is transmitted as an autosomal dominant characteristic and is characterized by an increased coproporphyrin III excretion
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even during states of remission (Goldberg et al., 1967).

The symptoms of

acute attacks have been found to be very similar to those of acute intermittent porphyria.
c.

Mixed porphyria or variegate porphyria

This porphyria is common among persons of European ancestry in
South Africa (Dean, 19-63) and is apparently inherited as a Mendelian .
dominant character.

Acute attacks similar to those of acute intermittent

porphyria occur most commonly in affected females, while photosensttivity
is found in male members of the same family.

Patients with South ·African

porphyria have a high fecal porphyrin contenf in states of remission, with
an increase in the urinary porphyrin, porphobilinogen, and ALA excretion
during acute phases of the disease.

The ph6tosensitiv1ty present in the·

variegate
porphyria
is due to the accumulation in the body of photo<;Iynam. .
.
.

.

.

,

-:.,

~.

ieally active porphyrins.
Rimington (1967) has isolatea hydrophilic porphyrins from the urine
and feces of patients with mixed porphyria and has found that excretion· of
these porphyrins is characteristic of mixed porphyria.

Norm.al persons

and patients with porphyrias of other types excrete these hydrophilic
porphyrins only in trace amounts if at all.
d.

Symptomatic or acquired porphyria

This nonhereditary type of porphyria is characterized by photosensitivity and an absence of acute attacks.

The excretion of porphyrins,

r.-------------
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especially urinary uroporphyrin, is very high, while the excretion of
porphobilinogen and ALA is usually normal.

Several types of acquired

porphyria have been described: (1) porphyria cutanea

ta~da

symptomatica

(Waldenstrom, 1957); (2) Bantu porphyriC;t (Barnes, 1959); (3) Turkish
porphyria (Cetingil and Ozen, 1960); and (4) porphyrin-producing hepatic adenoma (Tio et al.. 1957).

The porphyria which occurs in Bantus has been

reported _to be due to the hepatoxic. effect of aduJterated dri_n~s brewetj. a11d
sold in the urban areas, while the porphyda in Turkey was the result of the
ingestion of bread made from hexachlorobenzene-treated.breaci.
i.

The adverse effect of drugs on patients with hepatic

_porphyria
Certain drugs when administered to patients with either acute ·
intermittent or mixed ·porphyria can worsen the ·course of the disease and
also precipitate attacks in cases of la.tent porphyria.

Patients with the

genetic factor are very sensitive to these drugs and a very small amount has
been found to cause a response.

Waldenstrom (1939) and Goldberg (1959)

reported that barbiturates not only precipitate attacks in persons with latent
porphyria of the acute intermittent variety but they also seriously affect
.

the prognosis of the disease.

-

~

..

Dean (1963) also found that barbiturates may

precipitate acute attacks in persons with mixed porphyria.

Patients with

South African :i:nixed porphyria appear to be the most sensitive to barbiturates
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those with acute intermittent porphyria less so, and those with hereditary
coproporphyria even less (With, 1965).
Sulfonamides, nonbarbit urate sedatives and anticonvulsants, griseofulvin, an_d sex hormones have an been demonstrated to be capable of precipitating attacks of acute intermittent porphyria in patients possessing the
genetic trait.

Administration

ot chloroquine to

patients with symptomatic

porphyria results in an increased excretion of urinary uroporphyrin.
accompanied by transient fever, -tachycardia, and general malaise (Embree;
1961; Cripps and Curtis, 1962).

The increase in uroporphyrin excretion is

not accompanied by an increased excretion of porphyrin precu·rsors and it
therefore appears that chloroquine causes a

~elease

of stored uroporphyrin

from the liver {Sweeney et al., 1965h · Felsher and Redeker {196.6)hav·e
reported results which are in agreement with the suggestion that chloroquine causes a release of uroporphyrin fr~m the liver rather than an
increased synthesis of uroporphyrin by the liver.
ii.

Experimental hepatic porphyria

Drugs such as 2-allyl-isoprqpylacetamide {AIA) and 3, 5-diethoxycarbonyl-l,

4-dihy~rocollidine

(DDC) have been found to-induce experimental·

hepatic porphyria in both rats and rabbits (DeMatteis and Prior, 1962). Porphobilinogen and A LA were increased in the urine after treatment with these
drugs and this is the same biochemical picture as seen in human acute
intermittent porphyria.

Ockner and Schmid (1961) have demonstrated that
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rats fed 0. 2% of hexachlorobenzene in their diet excrete large amounts of
uroporphyrin and coproporphyrin and if the exposure is prolonged
porphobilinogen also increases.

This biochemical picture is similar to that

seen in patients with cutaneous porphyria in southeastern Turkey with the ·
exception that in the latter case porphobilinogen was not ·increased in the
urine.

Certain drugs, therefore, when administered to animals appear to

be able to produce porphy:i:'ic disturbances resembling.those present· in
human porphyria.
iii.

Mechanism of drug induced porph,Yria

Granick (1965)_ demonstrated that _porphyrog.enic drugs indu.ce de novo _
synthesis of A LA syrtthetase in culture-$ of chicken embryo liver. cells and
this observation has now been confirmed in the whole animal (Narisawa and
Kikuchi, 1965; Marver et al., 1966).

A recent report by Granick (1966)

stated that heme prevents the increased porphyrin production caused by.AIA
in cultured liver cells and he suggested that heme inhibits the increased
synthesis of ALA synthetase by acting as a specific co-repressor in the
regulation of this enzyme.

Porphyrogenic drugs may interact with the

portion of the apo-repressor molecule that normally binds heme and compete
with heme for this site. _ Heme wo_uldthep. be_ preyented from combin,ing
with the apo-repressor and the operator gene would be kept open for continuous synthesis of them-RNA necessary for synthesis of ALA synthetase.

43

METABOLIC FATE OF ALA

Trlcarboxylic
Acid Cycle

Succinate-gl ycine
· Cycle
· · a-Amlno-p~ketoadlpie acid.,

. .

rHOOC-CH 2 ~CH2 -ri-cHOJ.

L

o
Ketoglutaraldehyde
[O]

j

. )

J

.

-~

HOO
~
C-CH 2 -CH2 -C-CH 2 NH2 .
______ ... ,,
.

A

.

cl-Aminolevulllnic. acid

HOOC- CH 2 - CH 2 - C-COOH

.

n
0
a-Ketoglutaric acid

Porphyrln

SUCCINATE-GLYCINE CYCLE
Source:· Schmid, R. 1966 The Porphyrias. In "The Metabolic Basis of
Inherited Disease, Second Edition" (J.B. Stanbury, J.B. Wyngaarden, ·and
D.S. Fredrickson, eds.), pp. 813-870. ·McGraw-Hill, New York; Shemin,
D. 1955 The Succinate-Glycine Cycle; The Role of [' -Aminolevulinic Acid
in Porphyrin Synthesis. In Ciba Foundation Symposium on "Porphyrin
Biosynthesis and Metabolism" (G. E.W. Wolstenholme and E. C. P. Millar,
eds.), pp. 4-26. J. and A. Churchill Ltd., London.
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Shemin and Russell (1953) postulated a succinate-glycine cycle throug
which A LA can be oxidized back to succinic acid and this oxidation would
thus provide a pathway for glycine oxidation.
is the deamination of ALA to

The first step of this cycle

c< -ketoglutaraldehyde· which then

ALA-carbon derived from glycine to form succinate.

releases the

The ALA-carbon

derived from glycine provides the o.< -carbon atom to ureido groups of
purines, the $-carbon atom of serine, the methyl group of methionine,
and forms formic acid (Shemin et al., 1955).

I.

PHARMACOLOGICAL EFFECTS OF ALA
The symptoms of lead intoxication. and of acute intermittept porphyria

are very similar.

The clinical pictures are ch-aracterized by abdominal

pain, constipation, vo.miting, nc:mabdominal p_ain, and paralysis (Dagg et al. ,
1965).

In both diseases there is ·also a similar type of segmental demye-

lination of the peripheral nerves.

Secondary axonal degeneration found in

experimental lead poisoning by de Villa;.tercie (1929}ha;=;

~.lsq

been

de~cribed.

by Gibson and Goldberg (1956) in cases of acute intermittent porphyria.
Since A LA is increased in both the urine and blood of patients with either
lead intoxication or acute intermittent porphyria, it is tempting to assume
that A LA is responsible for the clinical pictures described above.
Berlin et al. (1954) a~d Scott (1955) administered ALA to humans
per os and Granick and Vanden Schrick (1955) and Jarrett et al. (1956)

r ·__--~--------,
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injected ALA into rats intraperitoneally or subcutaneously and the only
pharmacological effect observed was a transient but marked photosensitivity.
Jarrett et al. (1956) also showed.that ALA did not possess any pharmacological activity when tested in the anesthesized cat or with isolated guinea
pig ileum.

In the cat, ALA at a dose of 100 pg/kg body weight did not

alter the heart rate or blood pressure and neither potentiated nor inhibited
the responses to adrenaline or to nor-adrenaline.

ALA at a dose of 100 pg

in a 20 ml bath neither caused a contraction of the isolated guinea pig
ileum nor effected the contraction produced by histamine, by acetylcholine,
or by 5-hydroxytryptamine.

On isolated rat's colon, the same dose of ALA

had no effect and did not alter the response produced by acetylcholine or by
5-hydroxytryptamine.
This pharmacological evidence was strengthened when AIA was found
to produce experimental porphyria in rabbits, rats, and fowls (Goldberg
and Rimington, 1954-55).

Animals injected with this drug excreted large

quantities of ALA and PBG, yet showed no features similar to acute intermittent porphyria in humans apart from constipation and loss of weight.

In

addition cases of latent acute intermittent porphyria are known to excrete
large quantities of ALA and yet are symptomless.
Recently, Feldman et aL (1969) reported that ALA causes a reduction
in twitch tension in vitro on phrenic nerve stimulation of rat hemidiaphragm
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preparations (ED50 of 7. 5 mM).

When the miniature end-plate potential

frequency was augmented with 20 mM K+. 7. 5 mM ALA reduced it by 26%
and 15 mM ALA by 61%.

Dual microelectrode studies showed that ALA

caused a 3-fold increase in muscle membrane conductance and it was
conCluded that ALA inhibits the neuromuscular acetyleholine release.
J.

PURPOSE OF THE DISSERTATION
Lead poisoning in children is a major public health problem in large .

cities.

The possibility exists that this problem may be controlled by

carrying out large-scale screening programs designed for the detection of
early and potentially hazardous exposure to lead before the development of
frank lead intoxication.

Since numerous

~nv~stigators

have reported that

urinary ALA levels are increased in cases of adult lead intoxication and in
lead-exposed workers, a study of urinary ALA levels of children suspected
of lead ingestion was undertaken. ·This type of study employing urinary
ALA as a possible indicator for early lead poisoning has never been carried
out in children.
The studies which were undertaken had three objectives.

..

first,

the modification and simplification of the method described by Mauzerall and
Granick for the determination of urinary ALA levels, thus making the urinar
ALA test a practical screening procedure for the early detection of increased
lead absorption in children; second, making the urinary A LA test readily avail-

•

able for use throughout the country; and th.ird, the initial correlation of the
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urinary A LA test with the clinical incidence of childhood lead intoxication.

.

··'

CHAPTER II
MATERIALS AND METHODS

CHAPTER II
MATERIALS AND METHODS
A.

PREPARATION OF REAGENTS

1.

Sodium acetate, 1. OM.

68 g of NaC 2H o 2 · 3H 20
3

(J~

T. Baker

Chemical Co., Phillipsburg, N. J. , catalog no. 3460) are dissolved and
diluted with water to 500 ml. 0. 8% of boric acid is added as a preservative.
2.

Acetylacetone.

Obtaine_d under the name of 2, 4-opentanedione

(Eastman Organic Chemicals, Rochester, New York, catalog no. 1088)
and used undiluted.
3.

Modified Ehrlich's reagent.

10 g of para-dimethylamino-

'benzaldehyde U.S. P. {Matheson Coleman and BeU, Norwood, Ohio. catalog
no. 1606) is dissolved in 420 m.l of glacial acetic acid (E.T. duPont de
Nemours and Company,· Wilmington, Delaware) and 80 ml of 70%perchloric
acid (G. Frederick Smith Chemical Comp., Columbus, Ohio).
B.

PREPARATION OF ALA STANDARD
1.

Delta-aminolevulinic acid hydrochloride.

Obtained from

Calbiochem, Los Angeles, Calif. , catalog no. 1584.
2.

Acetate buffer, pH 4. 6.

5. 7 ml of glacial acetic acid and

13. 6 g of NaC 2H 3o 2 · 3H20 are diluted with water to 100 ml.
3.

A stock solution of ALA is prepared by dissolving 12. 5 mg of
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ALA hydrochloride with acetate buffer, pH 4. 6 to a 100 ml mark.

Each ml

of stock solution c.ontains 125 }lg of ALA· HCl which is equivalent to 100 )lg
of pure ALA.
C.

PREPARATION OF AN ALA STANDARD CALIBRATION CURVE
(1).

Six aliquots of the ALA hydrochloride stock solution (0. 01 ml,

0. 05 ml, 0. 10 ml, 0. 20 ml, 0. 30 ml and O. 50 ml) are pipetted into test
tubes and are used as working standards.
Volume of standard
stock solution
0. 01 ml
0.'05 ml
o. 10 ml
0. 20 ml
·o. 30 ml
0. 50 ml
(2)..

pg_ oJ AL~ per t()tal .
reaction volume

1 pg
5 pg
10 pg
20 }lg
. 30pg

_50pg

Dilute each of the working standards to 7. 0 ml with 1. Q M

sodium acetate.
(3).

Pipet 7. 0 ml of·l. 0 M sodium· acetate into an empty test

tube to be used as a reagent blallk.
( 4).

Add 0. 2 ml of acetylacetone to each test tube and mix.

( 5).

Place the test tubes in a_ boiling water bath for 10 minutes,

remove, and cool to room temperature.
.

(6).

Add 7. 0 ml of modified Ehrlich's reagent to each test tube, mix

and let stand for 15 minutes for complete color development.
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Read the optical density of the standards corrected for the

(7).

blank at 553 mp. in a spectrophotometer.

The optical path of the cuvette

is 1. 0 cm.
(8).

Prepare a standard curve by plotting the concentrations of the

standards against their optical densities.

1.

Effect of Varying the Amount of Acetylacetone

Ten sets of test tubes-with ·each set-consisting of a O. 05-ml. 0.10 ml.
and 0. 20 ml aliquot of the ALA hydrochlori~e stock solution were employed
in this experiment
was "diluted
to 7.
0. ml with 1. 0.. M - sodium
.
. and each-tube
.
... -·
.
.

acetate.

.

Reagent blanks. were prepared for each of the ten sets of test tubes

and to each set of tubes a different amount of acetylacetone was added (0. 01
.

-

ml, O. 05 ml. b.10 ml, 0. H>-ml, O. 20 ml, 0. 25 ml,
ml, and 1. 0 ml).

0.~3_0

ml, O. 40 nil, -0. 50 _-

After thoroughly mixing each tube, they were placed in a

boiling water bath for 10 minutes, then removed and cooled to room tempe:r:-.
Color_deve~<?pme~t

ature.

\Vas attained with

m<:>d~fied

Ehrlicli's reagent_ and

the optical densities of the A LA standards in each set corrected for the
appropriate blank were determined.
2.

Effect of Changing the Boiling Time -

Six sets of test

tube~

with each set

consi~ting

of a O. 05 ml, O_. 10 _ml,_

0. 20 ml. and O. 30 ml aliquot of the ALA hydrochloride stock solution were
employed in this experiment and each test tube was diluted to 7. 0 ml with

1. 0 M sodium acet-ate.

Reagent blanks were prepared for each of the six
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sets of test tubes and 0. 2 ml of acetylacetone was added to each test tube.
The test tubes were then mixed and each set of tubes was placed in a boiling
water bath for a different period of time (1 minute, 5 minutes, 10 minutes,
15

minutes~

20 minutes and 30 minutes).

Color development of the pyrrole
-

was attained with piodified Ehrlich's reagent and the optical densities of
the A LA standards in each set corrected for the blank determined.
3.

Stability of the Color Developed with Modified Ehrlich's Reagent

Six aliquots orthe ALA hydrochloride-stock -solution (O. 01 ml, 0. 05 ml,
0.10 ml, 0. 20 ml, O. 30 ml,· and 0. 50 ml) were placed-in test -tubes- and after
the appropriate steps, color development was attqined with modified Ehr1ich' s reagent. · The optical density of each tube corrected for the blank
was determined 15 minutes and also 2 hours after- the addition of the modifiedEhrlich's reagent.
4.

Stability of Refrigerated Modified Ehrlich's Reagent

A solution containing 10 g of para-dimethylaminobenzaldehyde (DMAB)
in 420 ml of glacial acetic acid was prepared and a
solution was removed.

ioo

ml aliquot of this

The remaining 320 ml was placed in a refrigerator

where it was frozen arid stored for future experimentation.

To the 100 ml.

aliquot 19 ml of 70% perchloric acid was added and the formed solution constitutes fresh modified Ehrlich's reagent.

A standard calibration curve was

prepared as described under the section "PREPARATION OF AN ALA STANDARDCALIBRATION CURVE" and this fr-esh modified Ehrlich's reagent was
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used for color development.

A 100 ml aliquot of the glacial acetic acid sol-

ution containing DMAB was removed 5 days, 10 days, and 15 days after
initiation of freezing and modified Ehrlich 1 s reagent was prepared from eac
of the aliquots.

An A LA standard calibration curve was prepared using

each of the modified Ehrlich's reagents and the optical densities of the A LA
standards were compared to one another.
D.

PREPARATION OF DISPOSABLE CHROMATOGRAPHY COLUMNS

PREPACKED WITH AN ION-EXCHANGE RESIN
In order to .isolate A LA from urine, the urine sample must first be
passed through an anionic exchange resin which permits the A LA and urea
to pass through while retaining porphobilinogen.

The effluent passing

through the anionic· resin must then be passed through a cationic exchange
resin which retains A LA while allowing the urea to pass through.

The

anionic resin employed in the following experiments was AG l-X8, 100 to
200 mesh, acetate ionic form.

The cationic exchange resin was AG 50W-X4,

100 to 200 mesh, hydrogen ionic form.
A slurry of either AG l-X8 resin or AG 50W..,X4 resin was made in
water using 3· g of the respective resin and 7 ml of water for each column to
be prepared. A 10 ml aliquot of the slurry was then pipetted into the appropriate disposable plastic chromatography column (Bio-Rad Laboratories)
with the aid of an automatic syringe and the resin was held in the column by
a glass wool plug placed in the bottom cap of the column.

A second glass
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wool plug was placed on top of the resin in order to prevent distortion of
the resin bed.

Using this method a column measuring 2 cm in height and

1. 6 cm in diameter resulted.

E.

PROCEDURE F.OR THE PETERl\/UNA TION OF URINARY A LA
The ·procedure used for the determination of urinary ALA is illustrate

in Figure 1 and is as follows:
(1).

Insert a dual disposable chromatographic _co!umn

~etup

in, the

support rack with the column containing the anionic AG l-X8 resin on top
and the column containing the cationic AG 50W-X4 resin on-the bottom.
(2).

Wash the top column with 10 ml of water and allow to drain

through both columns into the drain tray .
. (3). · Apply 0. 5 inl of a random urine sample to the top column after
having determined that the pH of the urine is 6 or befow.
(4)~

Wash the top column three times with 10 ml of water and allow

the water to drain through both columns.
(5).

Discard the top disposable column.·

(6).

Place the bottom colum.n in a test tube (20xl50 mm).

Add 7. 0 m

ofl. 0 M sodium acetate to the column and collect-the eluted A LA inthe test tube.
(7).

Discard the bottom disposable column and add 0. 2 ml of

acetylacetone to the test tube and mix.
(8).

Place the test tube in a boiling water bath for 10 minutes.

(9).

Add 7. 0 ml of modified Ehrlich's reagent to the cooled test tube.
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(10).

Read the optical density corrected for the blank after 15 minutes

at 553 mp in a spectrophotometer and determine the concentration of A LA
in the ·urine sample from the standard calibration curve.

Normal values

of urinary A LA produce a faint yellow color, w:hile abnormally elevated
values produce a distinct red color.
For the urinary ALA analysis, disposable pipettes, test tubes, and
columns were used.

An automatic pipetting machine was utilized for the

addition of water and sodhim·acetate to the columns.

Figure 2 shows the

·applicafron ·of the· urine samples to the columns and the utilization of a
hand-operated continuous syrfoge type. pipetter for the application of the
water and sodium acetate.

Theprocedure for urinary ALA _ana1y_sis as

described above has been found to permit one individual "to perform 200
determinations of

urina~y

A LA in approJ\imately only 4 hours or as many as .

1, 000 analyses in a normal work we.ek.
· 1.

Recovery of A LA fro in Columns

Forty-three piggyback column units were employed in this experiment
and O. 5 ml of an _aqueous solution (distilled water) containing 20 pg of A LA
per ml was applied to each of 25 columns, while LO ml was added to each of
the remaining 18.

The procedure for the determination of the A LA. content

of the solution was the same as described above for the determination of
A LA in urine.

The concentration of A LA in the aqueous solution was
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determined from the A LA standard calibration curve and this value was
compared to the known amount of ALA in the solution.

The per cent·

recovery of ALA from the columns was then calculated.
To determine the recovery of ALA from urine, ALA was added to
freshly voided urine, pH 4. 0-6. 0, from a normal individual in such a manner
so that a O. 55 ml aliquot of the urine sample would contain 5 pg of added
ALA +the normal ALA content of the urine, a 0. 60 ml aliquot would
contain 10 pg of added ALA+ the normal ALA content of the urine, and a
O. 70 ml aliquot would contain 20 ;ig of added ALA + the normal ALA content
of the urine.

Four columns each received a 0. 5 ml aliquot of the normal

urine and 0. 55 ml, 0. 60 ml, and 0. 70 ml aliquots of the urine samples
containing the added ALA.
th~n

The per cent recovery of the added ALA was

determined.
2.

Variation between Duplicate Samples

A O. 5 ml aliquot of urine from a normal individual was added to each
of five piggyback column units, while a O. 5 ml portion of urine from
an
I
individual with lead exposure was added to each of a second set of iive
columns. The ALA concentration of both the normal and high ALA urines
was determined by each of the five columns to which they were added and the
variation in ALA values between the columns
samples calculated.

re~eiving

the same urine

r.
56
3.

Effect of Varying the Mesh Size of the AG

50\iV-X~

Resin

A 10 ml aliquot of water was passed through each of twelve columns
prefilled with AG l-X8 resin, 100 to 200 mesh, and the time required for
the water to pasg

t?r~u~h ~ach

column was noted.

The time required for

10 ml of water to pass through columns prefilled with AG 50W...;X4 resin of
either 20 to 50, 50. to 100, 100 to 200, or 200 to 400 mesh was also determined.

The AG l-X8 columns were then placed on top of the AG 50W-X4:

columns forming piggyback column units.

The piggyback units were then

divided into three series each consisting of an AG l-X8 column on top of
an AG 50W-X4 column of either 20 to 50, 50 to 100, 100 to 200, ·or 200 to
400 mesh.

The time required for 10 ml- of -water to pass through each of

these piggyback column units was then determined.

To each column in the

first series, a 0. 5 ml aliquot of an aqueous solution (distilled water) ·
containing 20 )lg of ALA per ml was added.
second series, a

·o. 5 ml

To each of the columns in the

aliquot of urine from a normal individual was added ..

while each of the columns in the third series received a 0. 5 ml aliquot of
uri~e

from a lead:exposed

~ndividual.

The piggyback column units were

washed three times with 10 ml of water and the time required for each wash
..

to pass through the column units was determine<:J.

The top column

containing AG l-X8 resin was discarded and 7. 0 ml of 1. 0 M sodium acetate
was added to each of the bottom AG 50W-X4 columns.

The time required
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for the 7. 0 ml aliquot of sodium acetate to pass through each column was
noted and the pH of the sodium acetate eluate was determined.

Color

development was attained as previously described and the recovery of A LA
from the columns receiving the same sample was calculated.
4.

Effect of Urine pH- on the R.ecovery of ALA from Ion-Exchange

Columns
A O. 2 ml aliquot of an aqueous_solution containing 500 pgofALA per

ml was added to each of 10 test tubes.

To each of these tubes 9. 0 ml of

normal urine, pH 5.1, was added and the pH of the urines was adjusted with
hydrochloric acid and sodium hydroxide to either 1. 0, 2. 0, 3. O, 4. O,
5. 0, 6. 0, 7. 0, 8. 0, 9. 0, or 10. 0.

The total volume of each tube was then

adjusted to 10 ml With norm«il urine.

A 0. 5 ml aliquot oT urine from-each-

of the tubes was then added to a different piggyback column unit and the
optical density of the ALA eluted from each column was determined as·
previously described.
Similar experiments using 1 M sodium carbonate and hy_drochloric
acid and ammonium hydroxide and hydrochloric acid to adjust the pH of
urine were also performed.
F..

COLLECTION OF URINE SAMPLES FOR. THE CORRELATION OF

URINARY ALA VALUES WITH CLINICAL IMPRESSION OF LEAD INTOXI:CATION

1.

Study Number_ 1
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The first investigation was performed during the months of February April, 1967 and concerns 250 children living in high-incidence areas of lead
poisoning in the city of Chicago who were found by the Chicago Board of
Health Division of Laboratories to have an initial blood lead value greater
than 40 pg/100 ml as measured by atomic .abso~ption .sp~ctrometry.

The

percentage distribution of the initial screening blood lead values of the 2 50
children studied was 72% of the population between 40 and 59 pg/100 ml;
13% between 60 and 69 )lg/100 ml; 8% between 70 and 79 pg/100 ml; 3%
. between -80 and 99 pg/ioo ml; 3% between 100 andl49pg/!OQ ml; and-lo/~__
between 150 and 200 pg/100 ml. Following the initial blood lead determinat~o~, .
each c:hilc1 was referred to _the Ch_icago Boa.rd- of Health. Lead Clinic .
-located at -Municipal Contagious Disease Hospital for clinical examinationof possible increased lead exposure.

The ages of the children studied

ranged from 9 months to 6 years with the majority of children (83%)
being between the ages of 1 and 4

years~

Of the children stuc:iied 11% were

white and 89% nonwhite, 51 % male and 49% female.

A random urine

sample for the analysis of delta-aminolevulinic acid (ALA) was obtained
from each child during as many clinical visits as was possible.

A total

number of approximately l,. 000 urine samples were analyzed for urinary
ALA content.

The random urine samples were collected usfng 15 ml

capacity disposable plastic tubes and stored in the dark in a freezer
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prior

to the

analysis of urinary ALA.

All determinations of urinary ALA

were performed within 1 week after collection.

Urinary A LA is extremely

stable following the above storage procedure since it has been found that
.

·-

.

keeping frozen urines in a dark freezer for a period of 1 year_ results in
only a 5% decrease in the original ALA content.
2.

Study Number 2
-

-

Random urine samples were obtained during the months of May August, 1967 from a second group of children who had initial screening
blood lead values greater than 50 pg/lOD ml and were examined for possible
lead ingestion at Municipal Contagious Disease Hospital. . This group . ·
consisted of 534 children and a random urine sample was obtained from
each. child during. as many subsequent visits to MCDH as was possible.
~ sp~cia~ atte~pt_

was _made to_obtain _s_!IC<;!es_siveda}ly random urine sampl_e

from all children receiving chelaHon therapy for lead exposure.

A total

number of 1, 831 urine samples from the 534 ehildren were analyzed for
- urinary A LA content.
G.

CORRELATION OF URINARY ALA VALUES WITH CLINICAL

IMPRESSION OF LEAD INTOXICATION
Each child referred to the Chicago Board of Health Lead Clinic had -a thorough history and physical examination as well as a number of the
commonly employed laboratory tests for le_ad exposure.

The clinical and
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laboratory findings on each child's chart were summarized and compared
with the corresponding urinary A LA level obtained.

In addition, the

presence or absence of a clinical diagnosis of lead ingestion in each child
was compared with the urinary ALA level of the same child.· The examining
physicians at the Chicago Board of Health Lead Clinic were in no instance
aware of the urinary ALA level of the patient when arriving at a decision
as to possible therapy for lead exposure, thereby permitting a single--blind
type of clinical study to establish a relationship between urinary ALA levels
and possible lead exposure.

The administration of either calcium disodium

edetate or penicillamine by the examining physician on the basisof all
clinical and laboratory data except the urinary A LA level was taken as a.
-

clinical impression of an increased lead exposure in the child.
H.

EPIDEMIOLOGICAL FIELD STUDY OF URINARY ALA LEVELS
A total of 5, 000 plastic disposable urine collection tubes were

distributed to nine Urban Progress Centers in order to determine the
frequency of elevated urinary A LA levels in children residing in highincidence areas of lead poisoning in the city of Chicago.

The location of

the Urban Progress Centers ·are listed below.
South Parkway UPC
Woodlawn UPC
Englewood UPC
South Chicago Unit
Division St. Unit

4622 South Parkway
· 1030 E. 63rd Street
839 W. 64th Street
9231 S. Houston Avenue
1940 W. Division Street
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Montrose UPC
Halsted UPC
Lawndale UPC
Midwest UPC

901 W. Montrose Avenue
1935 S. Halsted Street
3138 W. Roosevelt Road
9 S. Kedzie Avenue

A blood sample and a fresh urine sample were obtained from every child
examined at the Urban Progress Centers.

The urine samples were

refrigerated after collection and were sent with the blood samples to the
Chicago Board of Health.

As the urine samples arrived at the Chicago

Board of Health they were frozen and were picked up twice a week by our
laboratory in order to determine their A LA content.

The analysis of blood

lead was performed by the Chicago Board of Health Division of Laboratories.
The procedure as outlined to the technicians is as follows:

1.

Check the names on the tubes containing the blood samples,
number each, and enter the names and numbers into the
workbook.

*2.

Measure the volume of the blood sample with a pipette and
add this to 5 ml of 20% trichloroacetic acid (TCA ).

l\Il :<: well

on a mixer and centrifuge 5 minutes at 2 500 RPM.

I_';"C·cant

the supernatant into a labeled 50 ml tube.
3.

Add 2. 5 ml of 20% TCA to the packed precipitate, resuspend
by mixing and centrifuge 10 minutes at high speed.

4.

Pour this supernatant into the tube containing the first supernatant.

(AT THIS POINT THE SAMPLES MAY BE FROZEN).
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If the samples are to be run in the same day continue to step

#5.
Prepare standards having concentrations of 0. 2, 0. 4, 0. 8
and 1. 0 parts per million.

Place a 5 ml aliquot of each

standard into a 50 ml tube, add TCA and then proceed to
. step 5.
**5.

Adjust pH to 2.

2~2.

8 with Na.OH and TCA.
. ..

6.

Add 1 ml of 1% (aqueous) ammonium pyr.rolidine

dithioc~rba-

mat_e (APDC) made fresh each day.- Mix well.
7.

Add 2 ml methyl isobutyl ketone (MIBK) and mix well.

8. ·

Centrifuge 3 mim1:te_s and then aspirate top layer. ·Read in
atomic absorption spectrophotometer. .

NOTES: The following are the settings for the atomic absorption spectrophotometer:
Slit width - variable from 0. 05 to 0. 31
Support - compressed air (17-18 lbs

I sq

in)

Triple pass ·
Hot mode with variac
Fuel - Acetylene (1 - 1.1/ 2 lb.s

I sq in}

Elevator Height· - 2. 35 to 2. 4 (Adjust for greatest sensitivity).
Lamp - ll ma to 15 ma.
Scale expansion - IX

Wavelength - 283 mp
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All glassware and pipettes are put through a regular wash and then returned

to the laboratory where they are washed with a 1:1 dilution of concentrated
nitric acid.

They are then rinsed several times with distilled water,

rinsed with de-ionized water, and finally oven dried.

All standards and

solutions are stored in polyethylene bottles.
>:< 10 ml of blood are requested but usually only 5 ml are received.
Samples as small as 2 ml whole blood can be run satisfactorily, but
with 2 ml there is no concentration factor and the result is multiplied
by 2 1/2.
.
>:~~:<
Use one drop of thymol blue (1 % in methanol) which is deep rose in
TCA; the end-point is pale salmon.

I.

ANIMAL EXPERIMENTS
1.

Storage of Urine Samples

The pH of each urine sample was tested by indicator paper and
occasionally, when necessary, adjusted to a pH range of 4-6 by the
addition of a few drops of glacial acetic acid.

The urine samples were

then frozen and stored for future analysis of ALA.

Delta-aminolevulinic

acid levels were determined employing the dual disposable chroma.tographic columns as described previously.
2.

Urinary ALA Excretion of Rats Injected with Lead Acetate

Six male Sprague-Dawley rats 90 to 100 days of age and weighing
305 to 355 g were each placed in individual stainless steel metabolism
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cages and urine samples were collected in continuous two hour portions
with the aid of test tubes placed in a fraction collector.

After collecting

24 hours of normal urine, three rats were injected intraperitoneally with
1 mg/kg of lead acetate and three with 15 mg/kg.

The urinary ALA

excretion of each rat was determined before and after the adniinistra:tion
of lead acetate.
3. ·

··Urinary A LA Excretion of Rats Fed Lead Acetate-in.the· Dfet

Six male Sprague-Dawley rats 60 days of age and weighing· 210 to 230 g
were each placed in individual stainless steel metabolisrrt cages and the 24
"

.

hou.r -µrinary outputs of the rats were collected.

"'-....... __

After two days of collectin

normal urine samples, three rats were fed, ad libitum, diets containing
O. 1% and three were fed diets containing 1% lead acetate.

The lead

acetate diets were maintained for seven days and then the rats were
returned to a normal diet (powdered Rockland Rat Diet).

The urinary ALA

excretion per 24 hour urine sample was determined for each rat.
4.

Effect. of Calcium Dis odium Edetate pn the Urinary A LA

Excretion of Rats Fed a 1% Lead Acetate Diet
Six male Sprague-Dawley rats 60 to 67 days of age and weighing.220
to 265 g were each placed in individual stainless steel metabolism cages
and their 24 hour urinary outputs were collected.

After a three day control

period, three rats were injected intraperitoneally with 200 mg/kg of calciu
disodium edetate for three cons.ecutive days and then were fed a 1% lead

65

acetate diet for seven days.

The three remaining rats were fed a 1% lead

acetate diet for seven days and. were injected intraperitoneally with 200
mg/kg of calcium disodium edetate during the fourth through seventh day
of the lead acetate diet.

The 24 hour urinary A LA excretion from each

rat was determined.
5.

Effect of Various Metals on the Urinary ALA Excretion of Rats·

Male Sprague-Dawley rats 90 to 95 days of age and weighing 280 to
350 g were .each placed in individual st~inless steel metabolism cages
and their 24 hour urinary outputs were· collected.

After three days of

collecting normal urine samples, va.rious metals were administered to the
rats and each was administered as a

sing~e

intraperitoneal injection which

corresponded to approximately one-half its LD 50 dosage.· Three rats were
injected with each of the metals studied.

The metals and dosages that

were administereq c:i.re the following: lead acetate, 50 mg/kg; cadmium
chloride, 4. 5 mg/kg; bariu,m chloride, 15 mg/kg; ferrous sulfate, 100 .
mg/kg; zinc chloride, 19 mg/kg; strontium bromide, 500 mg/kg; copper
sulfate, 15 mg/kg; arsenic pentoxide, 2 mg/kg; titanium dioxide, 500 mg/kg
mercuric chloride, 2 mg/kg; and lithium chloride, 250 mg/kg.
lead was administered as a single oral dose of 10 mg/kg.

Tetraethyl

The 24 hour

urinary outputs of the rats were collected and the A LA levels were
determined.

r----------------------,
~-.
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Most of the metals injected into the rats were bivalent (lead, cadmium,
barium, iron, zinc, strontium, copper, and mercury) and were selected
in order to determine the specificity of lead in causing an increased
excretion of ALA in urine;

Tetraethyl lead was admfoistered to- determine

whether an organic form of lead is capable of increasing urinary A LA
excretion.

J.

STATISTICS EMPLOYED FOR THE ANALYSIS OF-DATA·
1.

Standard Deviation

s

~
.~ J.N-T

S

N

2.

=

standard deviation
sum of the deviations .from the
mean squared
number of individual
measurements

Comparison of Paired Observations by the t-Test
t

3.

=

sx2 =

=

d

s-d

sa

=
=
=

t ·value
mean difference
standard error of mean
difference

r

=

correlation coefficient
sum of the cross products XY
where X and Y are the deviations
from their respectiv~ means
sum of the deviations from the
mean squared for group X
sum of the deviations from the
mean squared for group Y

t
d

Correlation Coefficient
r

=

SPXY

J sx 2sy2

spxy· =

·sx 2 =
sy2 =
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4. · Chi - Square Test
x2

=

x2 =

[(ad-be) - N/?] 2 N
(a+b) (c+d) (a+c) (b+d)

N

a; b, c. and d

=
=

chi-square
total number of
subjects
components of a
2X2 contingency' ·
table

2X2 Cc;mtingency Table·

White Children
Number of Children
Having_ Normal Urinary
ALA Levels
Number of Children
Having Elevated
Urinary ALA ·Levels
Total

Negro Children

(a)

(b)

857

2507

(c).

(d)

22

190

Total
(a+b)
3364

(c+d)
212
..

(a+c)
879

(b+d)
2697

(N)

3576

.

r

CHAPTER ·III
RESULTs··

CHAPTER III
RESULTS
A.

MODIFICATION OF MAUZERALL AND GRANICK'S METHOD FOR

THE DETERMINATION OF URINARY ALA
The use of disposable plastic chromatography columns prefilled with
ion-exchange resin has made the determination of urinary ALA.levels a
practical laboratory

procedure~

The average completion time for one

individual to perform 40 measurements of urinary A LA has been found to be
approximately one hour, while 200 measurements of urinary ALA requires only 4 hoµrs.

Only six urinary ALA determinations could be performed in

one day using the method described
. Chad 1 presents

by

a typical A LA

Mauzerall and

Granick~

·

standard caiihration curve obtained

by followi~g the procedure described in the section entitled "Preparation of

an ALA Standarc:l_Calibration Curve." Urinary ALA .concentrations up to 10
mg/100 nil (10 ingo/o) can be determined from this curve without dilutfori of the
final red-colored reaction mixture. ·
Chart 2 presents the effect on final color development of changing the
amount of acetylacetone added to the ALA standards.

Color development·

of the formed pyrrole, 2-methyl-3-acetyl-4-(3-propionic acid) pyrrole, was
attained with modified Ehrlich's reagent and maximal development resulted
when 0. 10 ml of acetylacetone was added to the A LA standards.
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A decreased
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color intensity was not noted until 0. 30 ml of acetylacetone was added.

A

volume of 0. 20 ml of acetylacetone was therefore chosen as the quantity
to be used for the condensation of ALA in both the preparation of the
standard calibration curve and in the procedure for the determination of ·
urinary A LA,
Chart 3 presents the effect on final color development of varying the
boiling time of the sodium acetate solution containing ALA and acetylacetone.

Color development of the formed pyrrole was attained with modified

Ehrlich's reagent and maximal development was found to occur when the
sodium acetate solution was boiled for 5 minutes.

The color intensity

remained maximal even when the sodium acetate solution was boiled for
periods up to 30 minutes.
chosen to be_used

i~

A 10 minute boiling pe!'iod was therefore

tpe preparation -of._the ALA
-

.

standa~d
- .

calibration cl,.lrve

and in the procedure for the determination of urinary ALA. - Chart 4-presents the stability of the color developed with modified
Ehrlich's reagent.

The optical densities of the ALA standards when read

15 minutes and 2 hours after the addition of modified Ehrlich's reagent are
similar and thus

t~e

color formed with this reagent is stable for at

leas~

2 hours.
Table 1 presents the stability of refrigerated modified Ehrlich's
reagent .. When glacial acetic acid solution containing DMAB is frozen for

r---~

_ _ _ _ _ _ ____,
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periods up to 15

~ays

and is then used for the preparati?n of modified

Ehrlich's reagent, the color of the A LA standards developed with this
Ehrlich's reagent is exactly the same as that produced with fresh reagent.
Table 2 indicates the expected results using the modified method for
the determination of urinary ALA.

The limit of detectability of ALA in

urine is 0. 03 mg/100 ml; the sensitivity of the test is ().15 microgram;
the variation between duplicate samples is.::!::_ 3o/o; the recovery of A LA from
aqueous solution is 97%; and the recovery of ALA from urine is 93%.
Table 2a presents the recovery of ALA from aqueous solution (distilled
water) using the piggyback column. method.

When aliquots containing either

10 or 20 pg of ALA were placed on piggyback column units, the recovery of
ALA was 94. 9 : !: _ 5. 4% and 100. 0 ::!::. 3. 4%, respectively.

Table 2b presents

the recovery of ALA from urine using the piggyback column-method.·· When
· 5, 10, and 20 )lg of ALA were added to normal urine samples, the percent
.

respectively.

. ·.. ·

93. 5 + 9. 5, -arid 93. 9 + 5. 0,

recovery of the added ALA was 92. 9 : !: _ 6. 8,

Table 2c presents the variation between duplicate samples

using the piggyback_ column method.

The_ concentration of A LA in the

urine of a normal individual was 0. 31 : !: _ 0. 02 mg/100 ml and in the _urine
.of a lead-exposed in~ividual was 1. 63 : !: _ 0. 05 mg/100 ml.
between duplicate samples was found to be

::!::_

The variability

3%.

Table 3 presents the results of changing the mesh size of the AG
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50W-X4 resin.

A 25% recovery of ALA was obtained from columns pre-

filled with AG 50W-X4 resin, 20 to 50 mesh.
100, a 58% recovery of ALA was attained.

When the mesh was 50 to

Columns prefilled with 100 to

200 mesh AG 50W-X4 resin yielded a 97% ALA recovery,· while columns
containing 200 to 400 mesh gave a 94% recovery of ALA.

Since the time

required for 7. 0 ml of 1. 0 M sodium acetate to flow through the 20 to 50
mesh column was. 54 seconds as compared to 4 minutes 33 seconds for the
100 to 200 mesh, it a,ppea~s that the ~od.i.um acetate pa,s$e~ through t h.e
·••

larger mesh columns so rapidly that it can not quantitatively elute off the
retained A LA. .Jt was of interest

tO note that the

pH of the sodium acetate

eluate ranged from 4. 57 to 4. 71 depending on the mesh size of the AG
50W-X4 column.

Mauzerall and G:ranick have stated that A LA should be

condensed with acetylacetone at a pH of 4. 6 and using the presently
described method for the determination of urinary ALA, the pH of the sodium
acetate elu-ate is of such a niagnitud"e that it does not have to be adjusted
prior to the addition of acetylacetone.
Table 4 presents the effect of urine pH on the recovery of ALA from
disposable

ion-exchang~

columns.

Urine samples having a pH of from

1. 0 to 10. 0 were applied to piggyback column units and there-was found to
be an essentially identical recovery of ALA from those columns which
received urine samples with a pH of 1. 0 to and including 6. 0.

However,

when the pH of the urine sample was 7. 0 or above, a decrease in the
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recovery of A LA was noted.

It is therefore suggested that the pH of all

urine samples applied to piggyback column units be 6. 0 or below.
B.

CORRELATION OF URINARY ALA LEVELS WITH THE CLINICAL

IMPRESSION OF LEAD INTO XI CATION

1.

Study Number 1

Table 5 presents the percentage distrilaution Qf urinary ALA levels
obtained from 2 50 children suspected of lead ingestion as a result of having
an initial blood lead value greater than 40 )lg/100 ml.

A total of 187 ·

children (75%) were found to have a urinary ALA level less than 1. 00 mg/
100 ml, while 63 children (25%) were found to have a urinary ALA level of

1. 00 mg/100 ml or higher.

Following clinical examination with the physi- ·

cian unaware of the urinary ALA level of the patient, only 4 to 5 per cent
of children with a urinary ALA level less than 1. 00 .:r_ng/100 ml were
treated with chelating agents for lead exposure. However, 65 to 100% of.
the children with urinary ALA levels· of 1. 00 mg/100 ml or higher re- ·
ceived chelation therapy for lead· exposure.

This data indicates that the

practical upper limit of normal for urinary A LA values in children is .
O. 99 mg/100 ml. Since there was also an essentially linear increase in

the incidence of chelation therapy with progressive elevation of the urinary
ALA level from 1. 00 mg/100 ml to 10. 0 mg/100 ml, it seems feasible to
classify urinary A LA levels in children according to the code indicated in
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Table 5.

Urinary ALA levels between O. 00 and 0. 99 mg/100 ml may be

considered normal.

Urinary ALA levels above 1. 00 mg/100 ml can be

subdivided into five ranges with a l+ code corresponding to 1. 00 to 1. 49
mg/100 ml, a 2+ code corresponding to 1. 50 to 1. 99 mg/100 ml, a 3+ code
·corresponding to 2. 00 to 2. 99 rng/100 ml, a 4+ code corresponding to
3. 00 to 5. 99 mg/100 ml, and a 5+ code corresponding to greater than
6. 00 mg/ 100 ml.
Table 6 presents a comparison of urinary ALA levels with the
incidence of chelation therapy in 2 50 children with SU!;pected l_ead ingestion.
The urinary ALA test was interpreted as being correctly negative when a
child with a urinary-ALA level of foss than 1. 00 mg/10-0 ml was not treated .
with chelating agents following clinical _examination. _ Th.e urinary ALA.
test was interpreted as being correctly positive when a child with a
urinary ALA level of l. 00 mg/100 ml or higher was administered chelating
agents.

The minimum criteri~ used for the clinical diagnosis· of increased

lead exposure were two consecutive blood lead values greater than 60

pg/

100 ml coupled with either a definite history of pica or X-ray evidence of
lead ingestion.

Based upon an overall comparison of urinary ALA levels

with the incidence of chelation therapy iri childr~n ".'ith suspected lead
ingestion it can be stated that urinary ALA levels are 91 % accurate for
the clinical diagnosis of increased lead exposure.

The incidence of urinary
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ALA being false negative is only 3%, while the incidence of urinary ALA
being false positive is only 6%.
Table 7 presents a comparison of the various laboratory tests for
lead exposure in 250 children with suspected lead ingestion in terms of
frequency of abnormal test results.
-

Employing the single-blind type of

-

evaluation, 92% of all the children who were dis-charged without chelation
therapy after clinical

examin~tion

were found to have normal urinary A LA

levels, whereas 86% of all the children who received chelation therapy
after clinical examinatipn had abnormally elevated urinary A.LA values.
None of the other laboratory tests studied had a comparable degree of
•
accuracy for the detection of early lead exposure.
Table 8 presents a comparison of the various laboratory tests for
lead exposure in 2 50 -children with suspected lead -ingestion in terms of
frequency of associated chelation therapy.

Employing the sirigle-blind

type of evaluation, 96% of all the children with a normal range of urinary
A LA values were discharged without chelation therapy after clinical

examination, whereas 76% of all the children with an abnormally elevated
urinary A LA value did receive treatment for lead exposure following
clinical examination.

Again, none of the other tests studied could compare

with the urinary A LA test in terms of accuracy of detection of early
exposure in asymptomatic children.

Following clinical examination, only

22% of the children who originally had initial blood lead values greater
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than 40 pg/100 ml as determined by atomic absorption spectrometry were
treated with chelating agents for lead eA-posure.
Table 9 presents a comparison of mean urinary A LA values with
mean blood lead values in 250 children with suspected lead ingestion classified by range of urinary ALA levels.

Each blood lead value was deter-

mined at the same time as the urinary ALA value.

The mean blood lead

value which corresponded to normal urinary ALA levels less than 1. 00 mg/
100 ml was 48)1g/100 ml.

However, children with levels of urinary ALA

ranging from 1. 00 to 1. 49 mg/10.0 ml had a mean bloo? lead value of S5 )lg/
100 ml.

An increase in the urinary ALA level was accompanied by a

statistically significant corresponding increase fo blood lead levels.

The

significance for the correlation coefficients between mean urinary ALA and
mean blood lead values was P

<0. 001 for normal,

l+, 2+, and 3+ urinary··

ALA levels with P.( O. 01 for 4+ and 5+ urinary ALA levels.Table 10 presents the distribution of hemoglobin levels in children
suspected of lead ingestion classified by urinary ALA levels.

Of the 57

children with elevated urinary ALA levels, 22% had abnormal hemoglobin
levels (less than 10 g/100 ml).

Of the 166 children having normal urinary

ALA levels, 16% had hemoglobin levels less than 10 g/100 ml.
Table 11 presents the distribution of hematocrit values in children
suspected of lead ingestion classified by urinary ALA levels.. Of the 180
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children with normal urinary ALA levels, 18% had abnormal hematocrit
values {less than ·33%).

Similarly 18% of the 61 children with elevated

urinary ALA levels had hematocrit values less than 33%.
2. ·

Study Number 2

Table 12 presents the percentag€ distribution of urinary ALA levels
in children with suspected lead ingestion as a result of having an initial
blood lead level greater than 50 )lg/100 ml as determined by atomic
absorption spect:rometry.

A total of 371 children (69. 5%) had a urinary

ALA level less than 1. 00 mg/100 ml, while.163 (30. 5%) had

a urinary ALA

level above 1..00 mg/100 ml. .
Table 13. presents a comparison of elevated urinary AL..A. levels.with
the incidence of chelation therapy in children suspected of lead ingestion
as a result of having an initial blood lead value greater than 50 pg/100 ml.
As in the first study, in no instance was the examining physician awa!'.e of ..
the urinary ALA values when prescribing chelation therap.f.

The minimum

criteria used for clinical diagnosis of increased lead exposure was also
the same as before.

A total of 131 children were found to have urinary

ALA levels of 1. 00 mg/100 ml or higher and 68. 4· to 100% of these children
received chelation thera.py for lead exposure.

These results are in

accord with those obtained in the first study in which 65 to 100 % of the
children with urinary ALA levels of 1. 00 mg/100 ml or higher were treated.
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Table 14 presents a comparison of elevated mean urinary ALA values
with the corresponding mean blood lead values in children with suspected
lead ingestion.

Each blood lead value was determined at the same time as

the urinary ALA value.

The mean blood lead value which was found to

correspond to urinary ALA levels ranging from l. 00 to 1. 49 mg/100 ml was
-

60 )lg/100 ml.

.

-

-·-

.

.

.

-

The mean urinary ALA level which was found to correspond

to this 60 pg/100 ml was 1. 27 mg/100 ml.

The mean blood lead levels

which were found to correspond to mean urinary ALA levels of 1. 67, 2. 41,
4.10 and 7. 97 mg/100 ml were 74, 80, 95, and.127 pg/100 ml respectively.
Chart 5 indicates ·the typical response obtained when either calcium
disodium edetate, abbreviated as EDTA, or penicillamine, abbreviated as
PNCM, were administered to children with elevated urinary ALA values.
It was found that both calcium disodium edetate and penicillamine admin-

istration resulted in a rapid return to normal of previously elevated urinary
ALA levels.

A child with an initial urinary ALA level of 4. 50 mg/100 ml

after being injected intramuscularly with EDTA for five successive days
at a dose of 50 mg/kg per day was found to have a norrp.al urinary ALA
level on the fifth day of treatment.

A similar decrease was noted when

a child with an initial urinary ALA of approximately 2. 80 mg/100 ml was
given penicillamine orally at a dose of 2 50 mg per day for 14 successive
days.

C.
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EPIDEMIOLOGICAL STUDY OF UEINARY ALA LEVELS
Table 15 presents the results of an epidemiological study to determine

the frequency of abnormal urinary ALA values in apparently-well, asymptomatic children residing in high-incidence areas of lead poisoning in the
city of Chicago.

Random urine samples from a total of 4, 189 children

between the ages of 1and10 years were tested for urinary ALA content
by the piggyback column method.
had elevated urinary ALA values.

A total of 5. 90% of the children tested
Assuming that these results are

representative of the entire population of approximately 260, 000 children
residing in high-risk areas of the city. this data suggests a predicted
number of 15, 340 children in the entire city of Chicago who should be
strongly suspected of an increased exposure to lead on the basis of an
abnormally elevated urinary A LA screening test.
Table 16 presents the percentage distribution of the urinary ALA
levels of the 4, 189 children according to the Urban Progress Centers where
the children were examined.

A total of 7. 6, 8. 9, 5. 6, 6. 6, 2. 3, 3.1, 4. 2,

5. 8, and 8. 6% of the children examined at South Parkway UPC, Woodlawn
UPC, Englewood UPC, South Chicago Unit, Division Street Unit, Montrose
UPC, Halsted UPC, Lawndale UPC, and Midwest UPC, respectively,
had urinary ALA levels of 1. 00 mg/100 ml or higher.

The Midwest

UPC had the highest percentage of children with elevated urinary A LA
levels and it was found that 98. 3% of the children examined at this Urban
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Progress Center were Negro.

In contrast, the children examined at the

Division Street Unit had the lowest incidence of elevated urinary ALA
levels and only 5. 9% of the children examined at this Urban Progress Center
were Negro.
Table 17 presents the distribution of children with elevated urinary
ALA levels by age.

Of 227 children with urinary ALA levels of 1. 00 mg/

100 ml or higher, the highest percentage or 17. 2% were 4 years of age.
Only 4 children or 1. 8% were in the 1 year age group.
Table 18 presents the distribution of the urinary ALA levels of 3, 919
asymptomatic children classified by age.

It was found that 3. 9, 6. 9, 5. 3,

5. 5, 4. 0, 6. 4, 6. 3, 5. 3, 7. 6, and 7. 9% of the children in the 1, 2, 3, 4, 5,
6, 7, 8, 9, and 10 year age group, respectively, had urinary ALA levels
of 1. 00 mg/100 ml or higher.

The 10 year age group had the highest

percentage of children with elevated urinary ALA levels.
Table 19 presents the distribution of children with elevated urinary
ALA levels according to race.

In the epidemiological study, 24. 4% of the

children tested were white, 74. 8% were Negro, and 0. 8% were classified
as other.

Of 214 children with urinary ALA levels of 1. 00 mg/100 ml or

higher, 10. 3% were white, 88. 8% were Negro, and O. 9% were in the other
category.

r
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Table 20 presents the distribution of the urinary ALA levels of 3, 606

A total of 2, 697 Negro children

asymptomatic children classified by race.

were tested and 7. 0% were found to have elevated urinary ALA levels. Only
2. 5% of the 879 white children demonstrated an increased ALA excretion.
The difference between the number of Negro- children having elevated urinary
ALA levels and the number of white children is highly significant (P< 0. 001).
Table 21 presents the distribution of the_ children with elevated urinary
A LA levels according to sex.

and 47.1% females.

Of 4, 019 children tested, 52. 9% were males -

A total of 233 children had elevated urinary ALA levels -

-

and of this total 62. 7%-were males and 37. 3% were fetnales.
Table 22 presents the distribution of the urinary ALA levels of 4, 019
asymptomatic children classified by sex.

Of 2, 126 male children, 6. 9% had

urinary ALA levels of 1. 00 mg/100 ml or higher.
-

Only 4. 6% of the 1, 893

-

female children had elevated urinary ALA levels.

The difference ·in the

incidence of elevated urinary ALA levels between the two sexes is statistically significant (P< O. 005).
Table 23 presents the distribution of blood lead values in 3, 068 children
with normal levels- of -urinary A L..A..

Each blood lead value was determined

at the same time as the urinary ALA value.

Using a blood lead value of

60 pg/100 ml as the upper limit of normal, 3, 031 out of 3, 068 children with
normal urinary ALA levels also had normal ·blood lead levels.

Only 37

r------------~:,:'
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children with normal urinary A LA levels had blood lead levels greater than
60 pg/100 ml .

Table 24 presents the distribution of urinary ALA values in 3, i48.
children with normal levels of blood lead.

Only 2, 982 out of 3, 148 children

with normal blood lead levels also had normal urinary ALA levels.

A

total of 166 children with normal blood lead levels were found to have
elevated urinary A LA levels.

D.

ANIMAL EXPERIMENTS
Chart 6 shows the typical response obtainetl when rats were injected

intraperitoneally with a single dose .of either 1 mg/kg or 15 mg/kg of lead
acetate.

It was found that l mg/kg of • lead acetate, shown by
the open - circles,
-

did not cause an increased amount of urinary .ALA.

.~;...t;:

On the other hand,

15 mg/kg shown by the dark circles and equivalent to only 1/10 of the LD50
of lead acetate was capable of causing an increase in urinary_ A LA within
6 hours after injection, which reached a level of almost 5 mg/100 ml 24
hours after injection.
Chart 7 shows the effect on urinary ALA excretion of different concentratioris of lead acetate in ad libitum diets fed to adult rats.

Within i ·day,

a 0.1% lead acetate diet resulted in an elevation of the urinary ALA excretion
from a control level of 50 )lg/24 hours to 96 )lg/24 hours.

A 1% diet of lead·

acetate was found to cause an increase in urin·ary ALA excretion from
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50 to 400 pg/24 hours.

The urinary ALA excretion remained elevated

for the duration of the seven day feeding period of the lead-containing diet
and was found to return to normal following the· removal of lead frorri the
diet.
Chart 8 shows the effect of calcium disoditim edetate on the urinary
excretion of ALA in rats fed a 1% lead acetate diet.

The top graph shows

the elevation of urinary A LA caused by a 1%- lead acetate diet as previously described..

The middle graph shows the urinary ALA excretion

obtained when rats pretreated with calcium di sodium edetate were then fed
.

a 1% lead acetate diet.

.

The rats were injected intraperitoneally with 200

mg/kg of calcium disodium edetate fo~ three consecutive days prior to the
onset orfhe 1% lead acetate diet.

It was found that the calcium disodium

edetate itself had no effect on the urinary ALA excretion of normal rats.
In addition, the pretreatment of rats with calcium disodium edetate had no
effect on the increase in urinary A LA. excretion resulting from a 1% lead
acetate diet.

The bottom graph shows the urinary A LA excretion in rats

fed a 1% lead acetate diet for seven days and which were also injected
intraperitoneally with 200 mg/kg of calcium disodium edetate during the
fourth thru seventh day of the lead acetate diet. .The urinary ALA level was
observed to decrease from 424 pg/ 24 hours just prfor to the injection oi'
calcium disodium edetate to 197

pg/ 24 hours following it. The urinary ALA

excretion then remained depressed for the remainder of the seven day·

r
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period of lead acetate feeding.
Table 25 indicates the effect of various metals on the urinary ALA
excretion in adult rats.

Each metal was administered as a single intra-

peritoneal injection which corresponded to approximateiy one-half its
LD50 dosage.

Tetraethyl lead, on the other hand, was
administered as a
.
.

single oral dos.e of 10 mg/kg.

On Day O which was the day preceding admin-

istration of the various metals, the mean urinary ALA excretion per 24
hour urine sample in 36 adult rats was 37 )lg with an upper limit of normal ..
of 69 pg.

Mean values of urinary ALA on Day 1 following injection of lead

<:i.cetate rose to 291 pg, remaining elevated throughout the time periods
studied.

The difference between the urinary A LA levels obtained the day

before and the day after the injection of lead acetate is statistically significant (P ( O. 05).

Tetraethyl lead, which _is an o_rganic form of lead, did not

cause any inc:rease in the urinary ALA excretion of treated rats.

I.n addition,

none of the other metals studied, including cadmium, barium, iron, zinc,
strontium, copper, arsenic, titanium, mercury, and lithium were found to
produce a statistically significant increase in urinary ALA excretion.

r
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DISCUSSION

CHAPTER IV
DISCUSSION
A.

CHILDHOOD LEAD POISONING AS A PUBLIC HEALTH PROB.LEM
Lead poisoning in children is one of the major public health problems

in large cities.

In a three year period, 1959-1961, lead poisoning accounted

for 4. 7% of 9, 853 cases of accidental poisoning in children reported to the
Chicago B.OB;rd of Health, but was re$ponsible for nearly 80% of all deaths
due to accidental poisoning (Christian et al., 1964).

Of 61, 167 poisonings

reported to the New York City Poison Control Center between 1955 and
1963, 3% or 1, ·704 cases were due to lead (Jacobziner, 1966).

In Baltimore

from 1956 through 1964 there were 1, 337 known cases of lead poisoning in
children (Schucker et al., 1965).
New York City reported a 6. 3% mortality rate for childhood lead
poisoning from 1954-1964 (Jacobziner, 1966).

In Cleveland, Griggs et al.

(1964) reported that from 1952 through 1958 lead poisoning had a mortality

rate of 30%.

Between 1959 and 1963, a mortality rate of 25% was reported for

a group of 182 children treated for acute lead encephalopathy at Cook
County Children's Hospital in Chicago and this fatality rate occurred despite
the use of chelating agents and other techniques for reducing the intracranial
pressure.

Perlstein and Attala (1966) have found that in childhood lead

encephalopathy, the mortality rate is between 28 and 45%, and four out of
84
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five who survive have sequelae.

This sequelae includes mental retardation,

recurrent seizures, cerebral palsy, and optic atrophy.

Recurrent seizures

in their study was the most common sequela and occurred in 54% of the
surviving patients, while optic atrophy was the least common having occurre
in only 6%.
Lead has become a major cause of poisoning among children, particu larly those residing in the slum areas of large cities.

High risk areas for

lead poisoning exist in all large cities and these areas usually contain old,
dilapidated substandard homes.

In such homes children have a ready

access to flaking paint and broken plaster and due to a lack of parental
supervision these homes provide an excellent environment for lead poisoning.
The problem of lead poisoning is not, however, confined to the children in
the lower socio-economic groups since it has also been reported in children
from advantaged homes (Moncrieff et al. , 19 64).
Children between the ages of 1 and 6 are the main victims of lead
poisoning with those between 1 and 3 years comprising nearly 85% of the
cases (Jacobziner, 1966).

The two year age group contains nearly 54% of

all deaths due to lead intoxication.

Jacobziner (1966) in his epidemiological

study of childhood lead poisoning found no significant difference in the
mortality incidence based on sex, except among whites.

Here, deaths of

females outnumbered males two to one, however, the total number of deaths
were too few to warrant any conclusions as to whether the female is more

,
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vulnerable.
Lead poisoni.ng and lead encephalopathy in children are most frequently
encountered during the summer months. About 45% of the total number of
childhood lead poisoning cases reported in New York Citybetweenl954and1963
were found to occur between the months of June and September (Jacobziner, 1966)
Christian et al. {1964) have reported that80to 85%ofthe cases of childhood lead
poisoning occur during these months.

Lead poisoning, however, should not

be considered. strictly a summertime_. di_sease since a number of cases have
also been reported during

th~

winter months._ Epidemiological. studies

indicate that even though lead encephalopathy occurs more frequently during
the summer, asymptomatic lead poisoning is a year round disease.

The

reasons postulated for the seasonal variati()n in the number of lead poisoning
cases reported include= l} a metabolic disturbance caused by the actinic
rays of the summer sun which results in an increased lead absorption; artd
2) a greater opportunity during the summer months to ingest lead containing
paint used on the exterior surfaces of the home (Jacobziner, 1966).
B.

USE OF SCREENING TESTS FOR THE DETECTION OF EARLY LEAI

EXPOSURE
Lead poisoning will only be wiped out when old housing is eliminated
and new homes employing lead free paint constructed.

Since at present this

task is not possible, the best approach to the control of lead poisoning in
children would be the carrying out of large-scale screening programs

87
designed for the detection of early and potentially hazardous exposure to
lead prior to the development of the symptoms of frank lead intoxication.
The Chicago Board of Health has been able to obtain an average of 2, 000
venous blood samples per month from children residing in high-incidence
areas of lead poisoning in the city of Chicago as part of their blood lead
screening program.

This rate of collection would only be able to screen a

total of 24, 000 children per year and since there are at least 260, 000
children between the ages of 1 and 7 residing in these high-risk areas. an
annual screening program of only 24, 000 children does not seem adequate.
Another disadvantage to the implementation of a blood lead screening program is that the drawing of blood and the determinatfon of the lead content
in the blood both require highly skilled personnel.
In 1956 Mauzerall and Granick developed a colorimetric method for the
determination of the ALA content in urine.

Using this method Haeger-

Aronsen (1960) found that the concentration of urinary ALA is increased in
adult workers exposed to lead.

Several other investigators have also

demonstrated that urinary ALA levels are increased in cases of lead poisoning and in lead-exposed workers (deKretzer and Waldron, 1963; Kleinstein
et al.. 1963; Efe, 1964; Cramer et al., 1965; Cramer et al, 1966; deB:rroin
and Hoolboom, 1967).
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Urine

cont~ins

glucosamine and aminoketones and these compounds

represent potential interfering substances in the determination of urinary
A LA.

Shuster (19 56) reported_ that both glucosami~e and aminoketones

resembling ALA when heated with ethyl acetoacetate give condensation
products which react with para-dimethylaminobenzaldehyde to form colored
complexes.

However, the relative molar color yield of glucosamine and

_most of the aminoketones was much less than-that of ALA._
Mauzerall and Granick (1956) separated by paper chromatography the
Ehrlich positive products associated with the determination of ALA in
-

-

-

-

-

~

normal urine and found that only 10 to· 20% of these products was the pyrrole
corresponding to free ALA.

Another-20 to 40% behaved as the pyr;role

corresponding to an aminoketone

withou~ ~free

carboxyl grolJ.p e.g. amino

acetone and the remainder was an orgairlc solvent -insoluble inaterial such as
might be formed from glucosamine.

Shuster (1956) has shown that using the

ethyl acetoacetate method both aminoacetone and glucosamine give only a
10% relative molar color yield as com1fared to

ALA~

Mauzerall and Gran-

ick's method for the determination of urinary ALA uses condensation-with
acetylacetone at a pH of 4. 6 and "this method is less sensitive than the ethyl
acet9acetate method to color

~nterference

with high concentrations of amino

acids, ammoniaj or glucosamine." Thus, even though only 10 to 20% of the
total Ehrlich positive products in normal urine are

du~

to the pyrrole
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corresponding to free ALA, the color intensity of this 10 to 20% would be
far greater than that of the sum of the other products.

Haeger-Aronsen

(1960) has found that essentially all the A LA-like substances occurring in
increased amounts in urine from lead workers is ALA.
C.

URINARY ALA LEVELS OF CHILDREN SUSPECTED OF AN

INCREASED LEAD EXPOSURE
The choice of urine as the- biological sample to be used in a screening
program for the detection of early lead exposure in children has the
advantage that a large number of samples could easily be obtained .. Therefore, after reading the above reports it was deemed of interest to investigate the urinary A LA levels of children suspected of an increased lead
exposure.

The method described by Mauzerall and Granick was utilized,·

however, it was found that only six urinary ALA determinationscould be
performed in one working day.

The method of Mauzerall and Granick was

modified and the present study indicates·that the determination of urinary
ALA levels is now possible as a practical laboratory procedure.

As shown

in Figure 3, a complete kit for performing the analysis of urinary ALA is
now commercially available and utilizing this kit one individual can perform .
either 40 analyses of urinary ALA in one hour or approximately 1, 000
analyses in a normal work week.

The collection, handling, and storage of

large numbers of urine specimens has been found to be feasible because only
0. 5 ml of a random urine sample is adeq_uate for the quantitation of urinary

r.
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ALA.
Cramer and Selander (1967} have reported that collection of 24-hour
urine specimens is not necessary for the accurate quantitation of urinary
ALA slnce the ALA values expressed in mg/100 ml from freshly voided urine
specimens closely agree with those from 24-hour specimens.

The AL.A

output expressed in mg/ g creatinine in freshly voided urine was also found
to closely correlate with the values obtained from 24-hour specimens.

When

the urinary ALA output expressed in mg/100 m_l was compared to ALA out~
put expressed in mg/ g creatinine a strong positive correlation was obtained.
This thus indicates that it is not necessary to relate the urinary output of
ALA to the output of creatinine or to the specific gravity orurine.
Haeger-Aronsen (1960) collected freshly voided urine samples from
.

-

..

100 apparently healthy individuals (50 males, 50 females}, 20 to.65 years of
age, and reported a mean urinary ALA concentration of O. 29 mg/100 ml
with a standard deviation oJ
0. 01-0. 57 mg/100 ml.

o: 14.

The 95% confidence limit was found to be

Davis and Andelman (1967) reported that the normal·

urinary ALA level in children ranging in age from 9 months to 5 years aver-·
aged O. 22 mg/100 ml with a standard deviation of 0.16 mg/100 ml and a 95%
confidence limit of O. 54 mg/100 ml.
In the present clinical

s~udy

only 4 to 5%. of !he children with

uri~ary

A LA levels less than 1. 00mgI100 ml were treated with chelating agents for lead

r
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exposure.

This data indicates that the practical upper limit of normal

for urinary ALA values in children is O. 99 mg/100 ml.

Since the incidence

of chelation therapy was found to increase
as the urinary ALA levels in.
.

creased, it was possible to subdivide the ALA levels of 1. 00 mg/100 ml and
above into five ranges.

A l+ ALA code corresponded to an ALA level of

from 1. 00 to 1. 49 mg/100 ml, a 2+ code corresponded to 1. 50 to 1. 99 mg/100
ml, a 3+ code corresponded to 2. 00 .to 2. 99 mg/100 ml, a 4+ code corresponded to 3. 00 to 5. 99 mg/100 ml,· and a 5+ code corresponded to 6. 00
mg/100 ml and above.
A 91% agreement was found to exist between urinary ALA levels and
the administration of chelation therapy to asymptomatic children suspected·
of lead ingestion and this offers evidence that urinary ALA levels are useful
as a screening technique for the detection of childhood lead exposure.

The

incidence of urinary A LA being false positive was only 6% and this might
have been due to the fact that urinary ALA levels have been reported to be
the earliest indication oflead exposure (Efe, 19"64; Djuric et al., 1966). Since
the examining physician was unaware of the urinary ALA levels of the patients
in this clinical study, he would not be expeeted to administer chelating
agents in the absence of other signs of an increased lead exposure.
When comparing the various laboratory tests available for determining
increased lead exposure, it was found that none of these could compare with
the urinary A LA test in terms of accuracy of detection of early lead exposure
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in children. Employing the single-blind type of evaluation, 96% of all the
children with a normal range of urinary A LA values were discharged without
treatment after clinical examination, whereas 76% of all the children with
abnormally elevated urinary ALA values did receive chelation therapy for
lead exposure after clinical examination .. Only 22% of the children who
originally had initial screening bload lead values greater than 40 pg/100 ml
as determined_ ~-y ato_mic absor?tion spe_ctroID:etry_ w~re tr_eated _with
chelating agents.
When lead-poisoned children with elevated urinary ALA levels ·were
.

-

.

treated with chelating agents, the ALA levels returned to normal limits
within a few days.

Haeger-Aronsen (1960) treated lead-poisoned adults and

rabbits with chelating agents and also found that the excr.etion of ALA.in the.
urine decreased after initiation of treatment.

A return.of elevated urinary

ALA levels to normal after treatment with chelating agents ha~ been r'eported
by numerous investigators (Griggs, 1964; Koziolowa-Lipska and Gutniakowa,
1964; Selander et al., 1966; Selander, 1967). Haeger-Aronsen (1960) and
Selander et al. (1966) have also reported that the excretion of lead in urine
increases soon after the administration of chelating agents.

The fact that

the recommended chelat:i.on therapy for lead poisoning causes an increased·
excretion of A LA to return to normal limits provides additional evidence
that urinary ALA determinations correctly indicate abnormal lead exposure
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in children and adults.

The use of urinary ALA determinations as a

clinical index for following the therapeutic management of patients receiving
chelating agents for lead poisoning, however, is questionable since urinary
A LA 1 evels have been found to increase once chelation therapy has ended.

Griggs (1964) has reported that the reduction in the excretion of ALA from a
lead-poisoned patient treated with versenate was maintained for only a few
days; within two weeks excretion had returned to pretreatment levels.

Per-

haps the urinary ALA test is so seni:>itive the.t the small amount of l~ad Jeft_.
in the body after chelation therapy is capable once again of increasing the
urinary excretion of ALA.
It is generally recognized that the upper limit· of normal values for
blood lead in children approximates 60 pg/100 ml, with a level of 80 pg/100
ml or higher being indicative of frank lead intoxication (Smith, 1964; Greengard, 1966).

The data from this study -indicates that urinary ALA values·be-"-

low 1. 00 mg/100 ml which are considered normal values were associated
with blood lead levels which averaged below the accepted upper limit of normal of 60 pg/100 ml.

Urinary A LA levels above 1. 00 mg/100 ml which are .

considered abnormally elevated values were associated with blood lead values
above 60 pg/100 ml.

In the present study, children with a mean urinary ALA

level of 1. 22 mg/100 ml had a mean blood lead_ level of 65)1g/100 ml. _Selander et al. (1966) have found that in lead-poisonedadultsaleadlevelof60pg/
100 ml blood corresponded to an A LA value in urine of 2 mg/100 ml.

r
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It should be noted that the highest mean elevated value of urinary A LA

represents almost an eighteenfold increase over the mean normal value of
urinary ALA, while the highest mean elevated value of blood lead represents
only a threefold increase over the mean normal value of blood lead.
Lead poisoning in adults usually results from the accidental exposure
to lead in an industrial atmosphere, while in children is usually the result
of oral ingestion of chips of lead-containing paint primarily in tlre older
undercoats of paint.

The chronic nature of lead poisoning enables the

employment of a suitable screening technique carried out at periodic intervals which would detect an abnormal exposure to lead prior to the ..development of clinical symptoms.

Since lead is rapidly stored in the skeletaLsys-

tern shortly after exposure of the child, initially high blood lead levels may quick!;
decrease to normal values.

This can occur even if the exposed child has

an accumulation of potentially dangerous quantities of stored lead which can
be released at any time to cause the severe manifestations characteristic of
lead intoxication.

Therefore, unless blood lead values are determined within

a short period of time following exposure to lead, they may be of little value
in any annual screening program designed for detecting early
in asymptomatic individuals.

le~d

exposure

Saita and Moreo (1964) have shown that A LA _

levels remain elevated for at least three years following removal of the

r
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individual from the source of lead exposure.

This prolonged increase makes

it possible for the use of urinary ALA measurements in annual screening pro
grams for the detection of early lead exposure in asymptomatic individuals.
An additional advantage for the use of urinary A LA levels as a screening
technique is its low incidence of false-positive results.

In contrast, the

frequency of false-positive results obtained for abdominal x-ray films,
hematocrit determination, - hemoglobin determination, wrist x-ray films, and
blood lead values greater than 40pg/100 ml were 49, 64, 58, 68 and 78%,
respectively.

Coproporphyrin determination of urines obtained from

asymptomatic children living in high-incidence areas of lead poisoning has
been- reported to be 85% false positive (Davis and Andelman, 1967).
Children with lead poisoning have been reported to demonstrate
pronounced microcytic, hypochromic anemia.

a

In this study, however,

children having elevated urinary A LA levels had similar hemoglobin and _
hematocrit values as children having normal ALA levels.

It therefore

appears that an elevated urinary A LA excretion occurs prior to the onset
of anemia.
D.

URINARY ALA LEVELS OF ASYMPTOMATIC CHILDREN
The results of the epidemiological study indicate that 5. 90% of the

asymptomatic children residing in high-incidence areas of lead poisoning in
the city of Chicago have urinary A LA levels of 1. 00 mg/100 ml or greater.

r
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Since 260, 000 children reside in high-risk areas of the city, this data
suggests that 15, 340 children in the city of Chicago should be suspected of an
increased lead exposure on the basis of an abnormally elevated urinary A LA
screening test.

Of 227 children with urinary ALA levels of 1. 00 mg/100 ml

or greater, 17. 2% were 4 years of age and only 1. 8% were in the 1 year age
group.

Even though lead poisoning has been reported to occur most fre-

the highest percentage of children having elevated urinary ALA levels is in
the 9 and 10 year age groups.

This latter result can be explained by the

finding of Saita and Moree that urinary A LA revels may remain increased for
up to three years after removal of the individual from
exposure.

O~e

source of lead

If children had ingested lead when they were 6 or 7 years of age,

the A LA levels in their urine would

~emain

elevated until the age of 10 ..

· The epidemiological study showed that 7. 0% of the Negro children:
tested had elevated urinary ALA levels, while only 2. 5% of the white
children demonstrated an increased ALA excretion.

This disparity is

probably a reflection of the housing in which the children reside.

Since

.

homes in Negro ghettos are more dilapidated than those in white neighborhoods, it is entirely reasonable to see such a· high incidence of lead poisoning
in Negro children.

Dilapidated homes provide a ready access to broken,

painted plaster from walls and paint peelings from window sills and ceilings.
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Jacobziner (1966) has reported that in 90% of the cases of childhood lead
poisoning, the affected child ingested chips of paint or plaster for several
months prior to the diagnosis of lead intoxication.

Since lead poisoning

associated with pica is a chronic process, it becomes apparent that there is
not only a necessity for new housing in slum areas but also a crying need
for closer parental supervision of children.
The epidemiological study also demonstrated that 6. 9% of the male
children tested had urinary A LA levels of 1. 00 mg/100 ml or higher, while
only 4. 6% of the female children had elevated urinary A LA levels.

Jacob-

ziner .(1966) also found that more cases of lea:d poisoning occurred in males.
In the present study, however, the· difference in the incidence between the
sexes is statistically significant.
E.

EFFECT OF VARIOUS METALS ON THE URINARY ALA EXCRETION

OF RATS ·
In the animal studies, rats were injected intraperitoneally with a
single dose of 15 mg/kg of lead acetate and an increased urinary A LA
excretion was demonstrated within 6_ hours.

This dose represents only

1/10 the LD50 of lead acetate and illustrates the rapid rise in the urinary
ALA excretion after exposure to a low dose of lead acetate.

Haeger-Aronsen

(1960) found that rabbits injected subcutaneously with lead acetate at a dose
of 125 mg/kg reached a maximum urinary ALA level on the thirty-fifth day
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after injection when
, it was 1. 96 mg/100 ml.

Rats injected with 15 mg/kg had

a value of almost 5 mg/100 ml 24 hours a,fter injection.

The rat, therefore,

appears to be an excellent animal to study the acute effect of chemicals and
drugs on urinary A LA excretion.
When each of sever al metals were administered to rats as a single
intraperitoneal injection which correspom;led to one-half its LD50 dosage,
inorganic lead was the only one found to cause an elevation of urinary A LA
excretion.

Tetraethyl lead, which was given orally, was found incapable of

causing an increased urinary ALA excretion.

Haeger-Aronsen (1960}

injected rabbits with either· cobalt, copper, zinc, arsenic, ·silver, lead, tin,
mercury' thallium, or bism?th and also found that lead was the only metal
capable of increasing the ALA content of the urine.

It was of particular

interest to note that the administration o_f copper, mercury, and zinc did
not increase the excretion of ALA by the intoxicated animals since Gibson

--·-

et al. (1955} have demonstrated that in vitro these metals have a much stron~

ger inhibitory effect on ALA dehydrase than lead.

If ALA dehydrase

inhibition was the sole cause for increasing the ALA excretj.on, these other
metals should also elicit an increased ALA content in the urine.
report by Heilmeyer (1967}

A recent

sh~ws that the normal metabolism of ALA to Vt-

dioxovaleric acid (DVA} is inhibited in patients with lead intoxication. Shemin
et al. (1953} were the first to show that ALA was metabolized to DVA and
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perhaps the inhibition of this pathway is important.

If lead causes a

build-up of ALA by inhibiting the ALA dehydrase enzyme c;i.nd then also
blocks the normal metabolism of ALA to DVA, there is no recourse but for
ALA to be excreted as such in the urine.
Goldwater and Joselow (1967) have reported that mercury-poisoned
individuals have a normal content of A LA in the urine and this agrees with
the rat data. _Tetraethyl lead expo_sed individuals nave also been_ shown tq
have normal urinary

ALA

levels (Koziolowa-Lipska and Gutniakowa,
1964;.
-.,

Gherardi and Vidoni, 1965).

It appears that only the inorganic form of lead

is capable of eliciting an increased urinary excretion of ALA.
F.

DISADVANTAGES OF USING A SINGLE CATIONIC COLUMN RATHER

THAN A PIGGYBACK COLUMN UNIT FOR THE ISOLATION AND DETERMINATION OF URINARY ALA
The presently used method for urinary A LA determinations employs
-two chromatography columns held in tandem position so that both the urille
sample and the water washes can pass through both columns consecutively.
The top column retains the porphobilinogen (PBG) and removes it as an
interfering substance in the colorimetric determination of urinary A LA with
Ehrlich's reagent.

In two recent reports (Williams and Few. 1967; Sun et al..

1969) it has been suggested that acceptible estimates of urinary ALA might
be obtained without prior removal of PBG and this is based on the assumption
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that PBG is little affected by lead absorption.

The available literature tends

to indicate that PBG levels in the urine become increased with the onset of
symptoms of lead poisoning.

Griggs and Harris (1958), Haeger-Aronsen

(1960). and deKretzer and Waldron (1963) have found that lead-exposed workers have normal levels of PBG in urine. However, Bashour (1954).
Tanabe (1959), Schlenker et al. (1964), and Gibson et al. (1968) have
reported that PBG is increased in ~he uririe of lead-poisoned individuals. In
addition to cases of lead intoxication, urinary PBG excretion has been reported to increase in diseases of the liver. including cirrhosis, as well as- a
number of anemias other than those due to iron-deficiency (Saita et al., 1966).
Williams and Few (19 67) state that their single column method might result
in falsely high values in pathological conditions such as porphyria.

The

possibility therefore exists that measurement of urinary A LA levels without the prior removal of PBG will result in a high incidence of false
positives for_ lead exposure due to urinary increases of PBG.

Since no

additional time is required for the urine sample to pass through both a top
anionic column which removes the PBG and a bottom cationic column which
retains ALA for subsequent elution, a dual disposable column unit measuring
urinary ALA levels alone is the method of choice.
-

However. if urinary ALA
-

levels are used as a screening technique for the detection of early lead
exposure in asymptomatic children. the cost of using the dual column units
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may be prohibitive.

Since children do not demonstrate acute intermittent

porphyria and liver diseases in childhood are rare, it may be possible to
use a single disposable chromatography column containing AG 50W-X4 resin
to obtain an acceptable estimate of urinary ALA for the early detection of
childhood lead exposure.

In industry where cost is not that important and

the number of workers to be tested not that large , the use of the dual
piggyb_ack .. column unit~ i_s recgmrriend_~cl·
G.

USE OF URINARY ALA LEVELS AS A SCREENING TECHNIQUE FOR

THE DETECTION OF EARLY LEAD EXPOSURE

In order to perform ·an annual urinary A LA screening program to
detect early lead exposure, large numbers of urine samples would have to
be collected. If 100, 000 random urine samples were to be· collected annually,
it would be necessary to obtain random urine samples from approximately
2000 children per week.

This can be accomplished by utilizing the following-

sources for collecting urine samples frorn children: . 1) community repre- sentatives as part of their normal assigned duties in visiting the homes in
slum areas; 2) high-risk infant welfare stations; and 3) neighborhood health
centers.

The major responsibility in collecting urine samples should lie
..

with the community representatives !epresenting the Urban Progress Centers
With the large number of community representatives available at the
Urban Progress Centers, each one would have to collect only a few urine
samples per day in order to attain the desired 2, 000 urine sa:nJ.ples per week.
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The utilization of the community representatives in obtaining the urine
samples would not involve any additional expense since they would perform
the collect_ion of urine samples

du~ing

the_ course of their normal visits.

The

only instruction necessary would be the proper labeling of the data-tab
attached to the urine coliection tube.

Each community representative would

fill out the data-tab and then s!ip it aro'llnd the urine collection tube which
is then filled with as little- as 1 to 5 ml of urine and stoppered.

At the end

of the day, the representatives would return their collected urine.samples
to their respective Urban Progress Center where they would be placed in a
freezer.

The following day these urine samples would be brought to the

laboratory where the determination of urinary ALA would be performed.
The urin-e can be stored in

a freezer pribr to the determination of its

A LA

content.
The following is the presently recommended procedure for the collection and storage of random urine samples whose ALA levels are subsequently to be determined: ·

1.

Place 0.1 ml of glacial acetic acid in an empty screw-capped

vial in order to insure that the stored urine will have a pH below 6.
2.

Collect a random urine sample.

It is advisable not to use the·

first voided morning specimen, late evening specimens after 8:00 P. M .• or
specimens obtained following excessive fl:µid intake.
concentration or dilution of the urinary ALA content. ·

This eliminates any

r
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3.

Add approximately 10 ml of the random urine sample to the

vial containing the glacial acetic acid, replace the cap, and gently mix.
· 4.

Place the vial in a refrigerator or freezer as soon as possible.

Excessive light exposure of the urine sample should be avoided prior to
storage since ALA has been found to be light-sensitive.

This can easily be

accomplished by placing the via.ls in either a dark brown plastic bag or a
light-tight box.

The urinary A LA content of samples stored in a dark

refrigerator will_ remain constant up to 4 months, while the urinary ALA
content of samples stored in a dark freezer have been found to remain
constant up to 1 year.
5.

After removal from storage, the urine in each vial should be
..

gently shaken to provide a homogeneous sample from which.to pipet the .
O. 5 ml aliquot required for the urinary A LA determination.
In order to test 100, 000 children for urinary ALA levels per year, it is
necessary that a total of 400 urinary ALA determinations be performed daily.
'this can easily be accomplished by using the previously described method.
A major advantage of the colorimetric determination of urinary A LA levels
in the visible spectrum is that normal values of urinary A LA produce a
colorless to faint yellow color, while abnormally elevated values of urinary
ALA produce a definite and distinct red color.

It is therefore possible in a

large-scale screening program to immediately classif.y all non·red colors
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as being normal A.LA values and determine only the optical densities of the
few red colored samples.

The optical densities of the samples can.be

quickly converted to mg/100 ml (mg%) of urinary ALA by using a conversion
chart as shown in Table 26.
Table 27 classifies urinary ALA levels irt terms of their rela.ti6nship
to lead exposure in children.
are considered to be normal,

Values of urinary A LA below 1. 00 mg/100 ml
indicat~ng

an insignificm:it .e:iq>QE;?..ure tQ

Je~d ..

Values of urinary ALA 1. 00 mg/100 ml or higher cari be considered to be
abnormally elevated with five subdivisions of increasing severity.

A l+

ALA code indicates a moderate exposure to lead; a 2+ indicates a heavy
exposure to lead; a 3+ indicates a severe exposure to lead; a 4+ indicates
a critical exposure to lead; and a 5+ indicates an overwhelming exposure ·to
lead.

The greatest·prlority should thus be given the children with highest

urinary ALA levels.

Children with urinary A LA levels corresponding to a

code of 5+, 4+, 3+, and 2+ should be immediately referred to a hospital for
clinical examination.

Such a clinical visit might include not only a history

and physical examination.· but also a blood lead determination, X-ray
examination of both the abdomen and wrists, and hemoglobin and hematocrit
determinations.

If desired, the determin;:i.tion of urin<;i.ry coproporphyrin

and basophilic stippling can also be performed.

Children with a urinary ALA

code of l+ should be scheduled for the earliest possible clinical examination
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after all the children in the range of 2+ to 5+ have been examined and treated
with deleading agents.
In summary, the following are the major advantages of using the
urinary A LA levels of asymptomatic children as a screening program for
the detection of early lead exposure:
1.

The collection of random urine samples is the only practical

method of obtaining biological specimens from thousands of small children.
2.

The determination of urinary ALA requires only O. 5 ml of a

urine sample.
3.

ALA is stable in frozen urine for at least one year and there-

fore urine samples can be collected and stored without any decrease in
their A LA content.
4.

On the basis of performing 400 urinary ALA determinations

per day, 100, 000 urine samples can be analyzed for their ALA content per
year.
5.

Urinary A LA levels are 91 % accurate for the clinical diagnosis

of increased lead exposure in children based on a single-blind type of
evaluation.
6.

Urinary ALA levels have a statistically significant relationship

to blood lead levels in children (p
7.

.C.

O. 001).

Urinary ALA levels remain elevated up to 3 years following
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exposure to lead, thereby permitting the implementation of an annual A LA
screening program.
8.

Elevated urinary ALA levels return to normal within 3 to 5 days

after calcium disodium edetate therapy and this indicates that urinary A LA
determinations correctly reflect an abnormal lead exposure in both adults
and children.
9.

The 5. 90% incidence of elevated urinary ALA levels found in the

4, 189 children residing in high-risk areas of lead poisoning agrees with the
predicted 6. 0% incidence of childhood lead poisoning based on the Department of Health, Education, and Welfares' figures for urban areas.
10.

A cute intermittent porphyria and occasionally certain liver

diseases are the only other pathological conditions besides lead poisoning
which cause an increased excretion of ALA in the urine.

Acute intermittent

porphyria does not occur in children and liver disease in childhood is rare
and therefore lead intoxication is the only known condition to cause an
increased ALA content in the urine of children.
11.

Finally, the cost of determining the A LA content of urine is

much less than the cost of performing most of the other laboratory tests
commonly used for the detection of an increased lead absorbance, e.g.
blood lead determination.

r

CHAPTER V

SUMMARY

CHAPTER. V
SUMMARY

1.

The method for the isolation of urinary A LA from random urine
samples has been modified utilizing a dual disposable chromatographic
column unit prefilled with resin that can be conveniently held in a
support rack over a drain tray.

The method for the colorimetric

determination of urinary ALA has been simplified by the elimination
of a number of transfer and dilution steps.

By using the presently.

described procedure, one indivi.dual is able to perform without
difficulty as many as 1, 000 analyses of urinary ALA in a normal
working week.
2.

A single-blind type of evaluation was made of the laboratory findings

and clinical impression of increased lead exposure versus the urinary
ALA levels obtained in each of 250 children suspected of lead ingestion.
In no instance was the examining physician aware of the urinary A LA
level of the patient when deciding on possible therapy for lead exposure.
It was found that urinary A LA levels are 91 % accurate for the clinical

diagnosis of increased lead exposure in children.

None of the other

laboratory tests studied had a comparable degree of accuracy for the
detection of early lead exposure.
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3.

It was found that a practical upper limit of normal for urinary ALA

levels in children is O. 99 mg/100 nil.

Elevated urinary ALA values

have been subdivided into 5 ranges of increasing severity with al+
code corresponding to 1. 00-1. 49 mg/100 ml; a 2+ code corresponding
to 1. 50-1. 99 mg/100 ml; a 3+ code cqrresponding to 2. 00-2. 99 mg/
100 ml; a 4+ code corres:ponding to 3. 00-5. 99 mg/100 ml; and a 5+
code corresponding to greate'r than 6. 00. mg/100 ml.

4.

A significant correlation was found to occur between levels of urinary
A LA and levels of blood lead as determined by atomic ·absorption
spectrometry in children suspected of lead ingestion.

The mean blood

lead values found to correspond to normal urinary A LA levels was .
48 pg/100 ml.

The mean blood lead values found to correspond to -

abnormally elevated urinary ALA levels ranged from 65 to 147 pg/
100 ml.
5.

The frequency of abnormal urinary ALA values in apparently-well,
asymptomatic children residing in high-incidence areas of lead·
poisoning in the city of Chicago has been determined.

Of 4, 189

children tested, a total of 5. 90% had elevated urinary ALA values.·
Based upon this data, it has been

predict~d

that nearly 15, 000 children

in the city of Chicago may suffer from an increased exposure to lead.
6.

In the epidemiological field study, the four year age group contributed

,ij
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the greatest number of children having elevated urinary ALA levels.
Negro children with elevated urinary ALA levels outnumbered white
almost nine to one and males outnumbered females almost two to one.
7.

Animal studies using adult rats indicate that a single intraperitoneal
injection of 1/10 the LD50 of lead acetate is capabie of causing an
increase in urinary ALA excretion within six hours.

8.

Tetraethyl lead was not capable of increasing the urinary ALA
excretion of adult rats.

9.

Pretreatment with calcium disodium EDTA did not protect against an
increase in urinary ALA excretion from adult rats subsequently fed
lead acetate.

However, caldum disodium EDTA when administered

during the period of elevated urinary ALA excretion, caused a rapid
fall in urinary ALA levels.
10.

Inorganic lead has been shown to be specific in causing an increased
excretion of urinary A LA from adult rats with respect to 10 other
metals tested (cadmium, barium, iron, z1nc~ strontium, copper,
arsenic, titanium, mercury, and lithium).

11.

It is suggested that urinary A LA levels are the earliest and most·
sensitive indicator of childhood lead exposure and that the- present
development of a practical laboratory method for the analysis of
urinary ALA can make possible

bo~h

large-scale screening for early
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lead exposure in asymptomatic individuals as well as the routine
determination of urinary ALA levels in all individuals suspected of
lead

intoxication~

The fact that about 15, 000 children in the city of

Chicago alone might suffer from an increased exposure to lead
emphasizes the need to carry out such large-scale .urinary ALA
screening in apparently-well, asymptomatic children before the
possible development of frank lead intoxication.

CHAPTER VI
FIGURES, CHARTS, AND TABLES

TEST PROCEDURE
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CATION
COl.UMN-

FIGURE 1
INDIVIDUAL STEPS OF THE TEST PROCEDURE FOR THE RAPID ANALYSI
OF URINARY ALA EMPLOYING PREFILLED DISPOSABLE PLASTIC CHROMATOGRAPHY COLUMNS ARRANGED IN PIGGY-BACK FASHION

111.

FIGURE 2
•\

Simplified system

for the isolation of ALA

from 40 sample s of urine

employing t w o dis-posable plastic chromatographic columns in tande m
-

position held by a support rack m e asuring 10 inches in length, 5 inches in
width and 10 inches in, height. , Left, The top column contains an anionic
·. - -

. exchange resin consisting of AG l-X8, 100 to 200 mesh, in the acetate
ionic form. · The bottom column contains_ a cationic exchange resin con sisting of AG 5.0W-X4, 100 to 200 mesh, in the hydrogen ionic form.
The columns are situated in the support rack above a suitable drain tray.
The urine sample is applied to the top column by inserting a pipette through
tile numbered hole in the top removable plastic sample guide and, after
passage through both columns , allowed to drain into the drain tray.

Center ,

Following removal of the pla stic sample guide, the top column is

FIGURE 2

washed with water allowing the water to drain through both columns into
the drain tray.

Right, Following removal of th e top column, the bottom

columns are placed in numbered test tubes held in a standard test tube
support rack.

Elution of A LA from the bottom c olumn into th e test tube

is then carried out with sodium acetate solution.
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FIGURE 3
COMPLETE KIT FOR PERFORMING THE ANALYSIS OF URINARY ALA
FROM 40 URINE SAMPLES, INCLUDING DISPOSABLE PLASTIC CHROMATOGRAPHY COLUMNS PREFILLED WITH AG l-X8 AND AG 50W-X4 RESINS,
SUPPORT RACK AND NUMBERED PIPET GUIDE, DRAIN TRAY AND ALL
NECESSARY REAGENTS.
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TABLE 1

STABILITY OF REFRIGERATED MODIFIED EHRLICH'S REAGENT

OPTICAL DENSITY at 553 Il1)l
Quantity of ALA per
14. 2 ml Final Reaction Volume

Day O_

Day 5

0.070

0.070
- 0. 163
o. 3"52
0.648
0.9001. 45

2 µg
5 µg

0~168

10 )ig
20 }lg
30 µg
50 ,ug

0.345
0.670
- 0. 940
1. 45

>"

DayH.>,: "·

Day 15

0.065
0.158
0.335
0.640
0.-925
1. 45

0.073
0.110.
0.355
0.645
0. 900 1. 40-
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TABLE 2
EXPECTED RESULTS USING THE MODIFIED METHOD FOR THE DETERMINATION OF URINARY A LA

Limit of detectability of A LA in urine .

0. 03 mg/100 ml

Sensitivity of test

0.15 )1g ALA

Variation between duplicate samples.

+ 3%

Recovery of ALA from aqueous. solution (distilled water) . . 97%
. 93%

Recovery of A LA from urine .

126
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TABLE 2a
RECOVERY OF ADDED ALA FROM AQUEOUS SOLUTION (DISTILLED
WATER) USING THE PIGGYBACK COLUMN METHOD

ALA Recovered (o/o)
10 )lg ALA Applied
to Column

x
S. D. +

20 )lg ALA Applied
to Column

87.5
98.4
98.4
103. 2
94.7
86. 8
92.7
101. 4
103. 8
103.8
85.0
92. 1
98.4
93.9
100.0
92.9
96.4
88.7
87.2
94.1
95.5
95.8
94.1
97. 1
91. 2

106.3
93.9
99.8
101. 6
103.1
97.2
103.2
103.2
99.8
96.5
95.3
103.3
96.8
96.8
100.0
103.3
100.0
100.0

94.9
5.4

100.0
+3.4

-
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TABLE 2b

RECOVERY OF ADDED ALA FROM URINE USING THE PIGGYBACK
COLUMN METHOD

ALA Recovered(%)

5 pg A I...A A pp_lied
to Column

l~pg

ALA Applied
to Column

20 pg ALA Applied
to Column

92.6
87.9
102. 5
88.5

89.2
91. 6
107.4
85.9

95.3
95. 3
86.7
98.4

92.9
S. D.+6. 8

93.5
+9.5

93.9
+5.0

x
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TABLE 2c
VARIATION BETWEEN DUPLICATE SAMPLES USING THE PIGGYBACK
COLUMN METHOD
.,

I\ LA Recovered from
Urine of Normal
Individual (mg/100 ml)

o. 31
0.32
0.27
0.32
o. 31

x
o. 31
>. D. -+ O. 03

Variation from
Mean(+%)

0.0
3.2
12. 9
3.2
0.0

3.9

ALA Recovered from
Urine of Individual
With Lead Exposure
(mgf 100 ml) ·

1. 70
1. 60
1. 61
1. 66
1. 56

'

1. 63
+0.05

-

'

Variation from
Mean(+%)

4.3

1. 8
1. 2
1. 8
4.3

2.7

TABLE 3
EFFECT OF VARYING THE MESH SIZE OF THE AG 50W-X4 RESIN*

Mesh Size of
AG 50W-X4 Resin

Piggyback
Flow Rateb

Flow Ratea

20-50

1 min 56 sec

6 min 33 sec 6 min 30 sec

6 min 33 sec

6 min 33 sec

50-100

2 min 42 sec

6 min 9 sec

6 min 8 sec

6 min 3 sec

100-200

6 min 30 sec

7 min 49 sec 7 min 46 sec

7 min 53 sec

7 min 40 sec

200-400

10 min 27 sec

Flow Rate
of 1st Washc

6 min 27 sec

11 min 43 sec 11 min40 sec

Flow Rate
Flow Rate ·
of 2nd Washc of 3rd Washc

11 min 47 sec 11 min 28 sec

*

Each Value represents the mean of two experiments.

a

Time required for 10 ml of water to pass through an AG 50W-X4 column.

b

Time required for 10 ml of water to pass through a piggyback column unit composed of an
AG 1-XB column on top of an AG 50W-X4 column. The time required for 10 ml of water to
pass through an AG l-X8 column alone was 5 min 47 sec.

c

Time required for 10 ml of water to pass through the piggyback column unit after addition
of O. 5 ml of an ALA sample to the AG l-X8 column.

1

·-....
TABLE 3 (Continued)
EFFECT OF VARYING THE MESH SIZE OF THE AG50Vv-X4 RESIN

Flow Rate of lM

pH of Sodium

% Recov;ery of

% Recovery of A LA

Sodium Acetated

Acetate Eluate

10 )lg ALA

from Normal Urinee

% Recovery of A LA
from the Urine of a
Lead-Exposed Indi•
vi dual

54 sec

4.69

25

35

31

....... 1 min 30 s.ec

4. 57

58

58

61

4 min 33 sec

4. 5'7

97

100

100

7 min 28 sec

4.71

94

97

98

~

......

-

d

Time required for 7. 0 ml of lM sodium acetate to pass through the AG 50W-X4 column.

e

100% recovery was arbitrarily set for the amount of ALA eluted from the 100-200 mesh
AG 50W-X4 column. The ALA eluted from the columns containing 20-50, 50-100, and
200-400 mesh resin were then compared to this value.

TABLE 4
EFFECT OF URINE pH ON RECOVERY OF ALA FROM COLUMNS

Optical Density at 553 mµ
pH
HCl + NaOH

HCl+NH40H

HCl +Na2C03

1. 0

o. 2'50

0.271

o. 241

2.0

0.245

0.289

0~252

3.0

0.232

0.260

0.256

4.0

0.249

0.273

0.230

5.0

0.225

0.260

0.230

6.0

0.232

0.240

0.228

7.0

0.210

0.225

0.212

8. 0

0.188

o. 161

0.200

9.0

0.127

0.022

0.095

10. 0

0.085

-----

-----
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TABLE 5
PERCENTAGE DISTRIBUTION OF URINARY ALA LEVELS IN 250 CHILDREN

l
I

I.

WITH SUSPECTED LEAD

<

I

E

Urinary A LA
(mg/100 ml)

Urinary A LA
Code

Number
Children in
Each Range

INGESTION>:~

% Total
Children in
Each Range

% Each Range

II

Treated With
Chelating Agents

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-

I

Normal range
0. 00-0. 54
0. 55-0.99
Abnormal range
1. 00-1. 49
i. so-i. 99
2.00-2.99
3. 00-5. 99
6. 00-10. 00

I

Normal
Trace
l+
2+
3+

4+
5+

123
64

49.2
25.8

4

27
14
12
8
2

10. 8
5. 6

65
70

4.s

84

3. 2
0. 6

100
100

5

>!'-All children had an initial blood lead level greater than 40 )lg/100 ml as determined by atomic
absorption spectrometry.

I

I
l

t

I

I

TABLE 6
COMPARISON OF URINARY ALA LEVELS WITH THE INCIDENCE OF CHELATION THERAPY IN
250 CHILDREN WITH SUSPECTED LEAD INGESTIO~>!<

t-'
CJ,;

B

Urinary ALA
Level

Chelation
Therapy

Interpretation
of ALA Test

Number
Children

Normal >!o!c

Not treated

Correct negative

179

High >!o!o!c

Treated

Correct positive

48

Normal >:o:c

Treated

False negative

8

High >!o:o:c

Not treated

False positive

15

~

>!< All children had an initial blood lead level greater than 40 ;p.g/100 ml as determined by atomic
absorption spectrometry.
>:o:c Normal range of urinary ALA

=

0. 00 to O. 99 mg/100 ml.

>!<>:o:c Abnormal range of urinary ALA = 1. 00 to 10. 00 mg/100 ml.

TABLE 7
COMPARISON OF VARIOUS LABORATORY TESTS FOR LEAD EXPOSURE IN 250 CHILDREN
WITH SUSPECTED LEAD INGESTION* IN TERMS OF FREQUENCY OF, ABNORMAL RESULTS

Children discharg~d without
Chelation Therapy
%with
Normal Test

Test

% with
Abnormal Test

·Children Treated with
Chelation Therapy

% with
Normal Test

% with
Abnormal Test

Urinary ALA

92

8

14

86

Wri~t

46

54

24

76

Abdominal X-ray

86

14

57

43

Hemoglobin

87 .

13

68

32

Hematocrit

85

15

71

29

X-ray

*All children had an initial blood lead level greater than 40 pg/1-00 ml as determined by atomic
absorption spectrometry.
·
Abnormal
Abnormal
Abnormal
Abnormal
Abnormal

urinary ALA = 1.. 00 mg/100 ml or higher
wrist X-ray = increased density at metaphysis
abdominal X-ray = radiopaque material in intestine
hemoglobin = less than 10. 0. g/100 ml
hematocrit = less than 33%

TABLE 8
COMPARISON OF.VARIOUS LABORATORY TESTS FOR LEAD EXPOSURE
IN 250 CHILDREN WITH SUSPECTED LEAD INGESTION* IN TERMS OF
FREQUENCY OF CHELATION THERAPY.

Test

% of Children with ·
Normal Test Values
Who Were Discharged.
without Treatment

% of Children with
Abnormal Test Values
Who Received Chelation
Therapy

Urinary ALA

96

76

Abdominal X-ray

82

51

Hemoglobin

81

. 42

Hematocrit

80

36

Wrist X-ray

85

32

Blood Lead

--

22

*All children had an initial blood lead level greater than 40 )lg/100 ml
as determined by atomic absorption spectrometry.
Abnormal
Abnormal
Abnormal
Abnormal
Abnormal
Abnormal

urinary ALA = 1. 00 mg/100 ml or higher
wrist X-ray = increased density at metaphysis
abdominal X-ray = radiopaque material in intestine
hemoglobin = less than 10. 0 g/100 ml
hematocrit = less than 33%
blood lead = greater than 40 pg/100 ml
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TABLE 9
COMPARISON OF MEAN URINARY ALA VALUES WITH MEAN BLOOD LEAD VALUES IN 250
CHILDREN WITH SUSPECTED LEAD INGESTION* CLASSIFIED BY VARIOUS RANGES OF
URINARY A LA LEVELS

Urinary ALA
Code

Number of
Children

Mean Urinary
ALA+ S. D.
(mg/100 ml)

Urinary A LA ·
Range
(mg/100 ml)

Mean Blood
Lead + S. D. **
· (µg/100 ml)

Normal A LA Values

...

Normal
Trace

123
64

o. 32 + 0. 13
0. 72
0 . .12

+

o. oo·-o. 54
0.55-0.99

48 + 11
49f. 11

27
14
12
8
2

1.22+0.14
i. 72 +o. 16
2. 45
o. 35
4. 66 0. 79
8. 69
1. 37

1. 00-1. 49
1. 50-1. 99
2.00-2.99
3.00-4.99
6. 00-10. 00

65 + 17
68
16
83
23
107
46
147
65

~

-:-

.;J

Abnormal ALA Values
l+
2+
3+
4+

5+

"·

+
+
+
-

+
+
+
+
-

* All children had an initial blood lead level greater than 40 )lg/100 ml as determined by atomic
absorption .spectrometry.
** Represents corresponding blood lead value at time of urinary A LA determination.

TABLE 10
DISTRIBUTION OF HEMOGLOBIN LEVELS* IN CHILDREN SUSPECTED
OF LEAD INGESTION** CLASSIFIED BY URINARY ALA LEVELS

Hemoglobin Levels (g/100 ml)
Urinary ALA
Level
Normal

,....
CA)

00

.

High

6.06.9

7.07. 9

. 8. 08.9

9.09.9

10. 010. 9

11. 011. 9

12.012. 9

13. 013. 9

14.014. 9

166

0

3

5

8

18

29

23

13

1

57

4

0

7

11

23

26

. 25

4

2

Total
Samples

-

*
**

Expressed as percent of total samples.
All children had an initial blood lead level greater than 40 )lg/100 ml as determined by atomic
absorption spectrometry.

Normal range of urinary ALA = 0. 00-0. 99 mg/100 ml
High range of urinary ALA

=L

00-10. 00 mg/100 ml

f"'

TABLE 11
DISTRIBUTION OF HEMA TOCRIT VALUES* IN CHILDREN SUSPECTED
OF LEAD INGESTION** CLASSIFIED BY URINARY ALA LEVELS

Hematocrit Values (%)
:.

Urinary ALA
Level

I

....

Total
Samples

.

21.23

2426

2729

3032

3335

3638

3941

4244

Normal

180

0

1

2

15

31

32

18

1

High

61

0

3

5

10

39

30

11

2

;,..)

:0

P:<

Expressed as percent of total samples.

** All children had an initial. blood lead level greater than 40 )lg/100 ml as determined by atomic
absorption spectrometry.
Normal range of urinary A LA
:ligh range of urinary ALA

= O. 00-0.

99 mg/100 ml

= 1. 00-10. 00

mg/100 ml ·

'J /

TABLE 12
PERCENTAGE DISTRIBUTION OF URINARY ALA LEVELS IN
534 CHILDREN WITH SUSPECTED LEAD INGESTION*

Urinary ALA
(mg/100 ml)

Number of
Children in
Each Range

Urinary ALA
Code·

% of Total
Children in
Each Range

Normal Range
0.00-0.54

Normal

251

47. 0

0.55-0.99

Trace

120

22. 5

69. 5

Abnormal Range
1. 00-1. 49

l+

64

12.0

1.50-1.99

2+

26

4. 9

2.00-2.99

3+

36

6.7

3.00-5.99

4+

27

5.0

6.00-10.00

5+

10

1. 9

*

'30. 5

All children had an initial blood lead level greater than 50 pg/100 ml·
as determined by atomic absorption spectrometry.
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TABLE 13
COMPARISON OF ELEVATED URINARY ALA LEVELS WITH THE INCIDENCE OF CHELATION
THERAPY'IN CHILDR.EN WITH SUSPECTED LEAD INGESTION>:<

......
......

i

%of Each·

Urinary ALA
Code

Number of
Child:r:en in
Each Range

1.00-1.49

1+

38

26

68.4

1. 50-1. 99

2+

23

18

78.3

2.00-2.99

3+

32

29 .

90.6

3.00-5.99

4+

28

28

100. 0

6. 00-10. 00

5+

10

- 10

100. 0

131

111

84.7

Urinary ALA
(mg/100 ml)

~ .

No. in Each
R.ange Treated
with Chelating
Agents

Total

*

R.ange Treated
with Chelating
Agents

All children had an initial blood lead level greater than 50 Jlg/100 ml as determined by atomic
absorption spectrometry.·
..

TABLE 14
COMPARISON OF ELEVATED MEAN URINARY ALA VALUES WITH CORRESPONDING MEAN
BLOOD LEAD VALUES IN 107 CHILDREN WITH SUSPECTED LEAD INGESTION*

Urinary ALA
Code

......
~

~

.

.

Urinary A LA
Range {mg/100 ml)

Number of
Children

Mean Urinary
A LA (mg/100 ml)

Mean Blood Lead
Cpg/100 ml)

1+

1.00-1.49

31

1. 27

60

2+

1. 50-1. 99

20

. 1. 67

74

3+

2.00-2.99

30

2~

41

80

4+

3.00-5.99

21

4. 10

95

5+

6.00-10.00

5

7.97

127

* All children had an initial blood lead level greater than 50 )lg/100 ml as determined by atomic
absorption spectrometry .

.

-----------------------------------------------------------------------------------.1'<.~·

TABLE 15
~ERCENTAGE DISTRIBUTION OF URINARY ALA LEVEL_8 IN 4, 189 APPARENTLY-WELL, ASYMPTOMATIC CHILDREN RESIDING IN HIGHINCIDENCE AREAS OF LEAD POISONING IN.THE CITY OF CHICAGO

·-

Urinary ALA
(mg/100 ml)

Number of
Children
in Each
Category

Urinary ALA
Code

% of Total
in each

Category

Normal range
0.00-0.54

Normal

3251

77. 61

0.55-0.99

Trace

691

16.50

1. 00-1. 49

1+

212

5.06

1.50-1.99

2+

20

0.48

2.00-2.99

3+

13

0.31

3.00-5.99

4+

2

0.05

94.11

-

-

Abnormal range

5.90
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TABLE 16
DISTRIBUTION OF THE URINARY ALA LEVELS* OF 4, 189 ASYMPTOMATIC CHILDREN
CLASSIFIED BY THE LOCATION OF THE URBAN PROGRESS CENTERS
WHERE THEY WERE EXAMINED

Number of Children Examined
at Each UPC

.....
~
~

Urinary ALA Levels (mg/100 ml)

o. 00-0. 54

0. 55-0. 99 1. 00-1. 49 1. 50-1. 99 2. 00-2. 99 3. 00-5. 99
18.0

6. 7

o. 6

0.2

o. 1

71. 4

19.7

7.5

0.9

0.5

0.0

588

79. 1

15.3

4. 4

0.5

o. 5

0.2

South Chicago Unit

121

76.0

17.4

6. 6

o. 0

0.0

0.0

Division St. Unit

258

82.2

15. 5

2.3

0.0

o. 0

o.o

Montrose UPC

259

78.8

18. 1

2.3

0.8

o. 0

0.0

Halsted UPC

857

82.0

13.8

3.7

0.1

0.4

o.o

Lawndale UPC

595

. 78. 5

15. 8

4. 9

0.7

0.2

0.0

South Parkway UPC

872

74.4

Woodlawn UPC

427

Englewood UPC

'

~

Midwest UPC

~c

212

72.6

18. 9

o. 5

7. 1 .

Expressed as percent of children examined at each UPC.

"

-

i. 0

o.o

TABLE 17
DISTRIBUTION OF CHILDREN HAVING ELEVATED URINARY
ALA LEVELS* BY AGE

Age (years)

Number of Children in Each
Age Group Having
Elevated Urinary ALA Levels

1

4

1. 8

32

14.1

3

35

15.4

4

39

17~2

5

31

13.7

6

32

14. 1

7

22

8

11

4.8

9

11

4. 8

10

10
--

2

Total

* Elevated Urinary ALA
**

o/o of Total

I

-

..

= 1. 00

4.4
-100.0

227**

Levels

9. 7

mg/100 ml or higher.

In this table the number of children reported to have had elevated ~rinary
ALA levels is less than the actual number found durLng the course of the
epidemiological field study. This difference occurs because in several
instances the age of the child having an elevated urinary ALA level was
not indicated on the physician's report form and therefore these
children could not be included in the table.

TABLE 18
DISTRIBUTION OF THE URINARY ALA LEVELS* OF 3, 919** ASYMPTOMATIC
CHILDREN CLASSIFIED BY AGE

Age
(years)
1

Number of Children in Each
Age Group Tested for Urinary A LA Excretion
103

UR.INARY ALA LEVELS (mg/100 ml)
0.00-0.99 1.00-1.49 1. 50-1.99 2.00-2.99 3·. 00-5. 99

o.o

o.o

o.~

0.4

0.2

4. 8

0.5

o.o

o.o

94.5

4.4

0.7

0.3

o. 1

96. 1

3.9

93. 1

5. 4

94.7

o.o
;

-

2

459

3

6.66

4

704
;

'

pi::.,

m

:

5

655

95~2

4. 1

0.5

0.2

o.o

6

502

93.6

6.0

0.2

0.2

o.o

7

353

93.7

5. 4

0.6

o. 3

o.o

8

206

94,7

5. 3

o.o

o.o

o.o

9

145

92.4

6. 2

o.o

1. 4

o.o

'

..

i

·10
o.o
5. 6.
0.8
1. 5
92.1
126
*Expressed as % of children in each age group tested for urinary ALA excretion.·
**In this table the number of asymptomatic children reported to have been tested for urinary ALA
.excretion is less than the actual number tested during the. course of the epidemiological field study.
This difference occurs because in several instances the age of the child tested was not indicated on
the physician's report form and therefore these children could not be included in the table.

TABLE 19
DISTRIBUTION OF CHILDREN HAVING ELEVATED URINARY
ALA LEVELS':c ACCORDING TO RACE

Race

Number of Children of Each
Race Having Elevated Urinary A LA Levels

% of Total

White

22

10.3

Negro

190

88.8

Other

2

0.9

Total

2 l 4::1c:>;c

*
**

Elevated Urinary ALA Levels

=

100.0

1.00 mg/100 ml or higher.

·In this table the number of children reported to have had elevated
urinary ALA levels is less than the actual number found during the
course of the epidemiological field study. This difference occurs
because in several instances the race of the child having an elevated
urinary ALA level was not indicated on the physician's report form and
therefore these children could not be included in the table.
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TABLE 20
DISTRIBUTION OF THE URINARY ALA LEVELS* OF 3, 606** ASYMPTOMATIC
CHILDREN CLASSIFIED BY RACE

Race

.......

Number of Children of
Each Race Tested for
Urinary ALA Excretion

URINARY ALA LEVELS (mg/100 ml)

o. oo-o. 99

·i. 00-1. 49 1. 50-1. 99 2. 00-2. 99 3. 00-5. 99

White

879

97.5

2. 2

0.2

o. 1

o.o

~egro

2, 697

93.0

6.0

o. 6

0.3

0.07

lather

30

93.3

6.7

o.o

o.o

o.o

~

O:>

* Expressed as

% of children of each race tested for urinary ALA excretion.

** In this table the number of asymptomatic children reported to have been tested for urinary ALA
excretion is less than the actual number tested during the course of the epidemiological field study.
This difference occurs because in several instances the race of the .child tested was not indicated
on the physician's report form and therefore these children could not be included in the table.

:i

TABLE 21
DISTRIBUTION OF CHILDREN HAVING ELEVA TED URINARY
ALA LEVELS>:< ACCORDING TO SEX

Sex

Male
Female
Total

Number of Children of Each
Sex Having
Elevated Urinary A LA Levels

% of Total

146

62.7

87

37.3

233>:0 !<:

100. 0

* Elevated Urinary ALA levels = 1. 00 mg/100 ml or higher.
** In this table the number of children reported.to have haa elevated urinary.
ALA levels is less than the actual number found during the course ·of the
epidemiological field study. This difference occurs because in s~everal
.instances the sex of the child having an elevated urinary ALA level.·~
was not indicated on the physician's report form and therefore these
children could not be included in the table.
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TABLE 22
DISTRIBUTION OF THE URINARY ALA LEVELS* OF 4, 019** ASYMPTOMATIC
CHILDREN CLASSIFIED BY SEX

Sex

~

Number of Children of
Each Sex Tested for
Urinary ALA Excretion

URINARY ALA LEVELS (mg/100 ml)

o. 00-0. 99

1. 00-1. 49 1. 50-1. 99 2. 00-2. 99 3. 00-5. 99

[Male

2,126

93.1

6. 1

0.5

0.2

o. 1

IFemale

1. 893

95.4

3. 8

0.5

0.3

o.o

0

* Expressed as % of children of each sex tested for urinary ALA excretion.
** In. this table the number of asymptomatic child.ren reported to have bee.n tested for urinary A LA
excretion is less than the actual number tested during the course of the epidemiological field study.
This difference occur.s because in several instances the sex of the child tested was not indicated
on the physician's report form and therefore these children could not be included in the table.

TABLE 23
DISTRIBUTION OF BLOOD LEAD VALUES IN 3, 068 CHILDREN WITH NOR.MAL
LEVELS OF URINARY ALA {O. 00-0. 99 mg/100 ml)

Blood Lead Levels (Jlg/100 ml}

0-9 10-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-89 90-99 100-129 130-300

IN o.

of children
~n each blood
ead range

...11
...

7

481

1246

868

334

95

o. 2

15. 7

40.6

28.3

10. 9

3.1

15

11

6

3

0.2

0.1

1

1

0

1% of children
in each blood
lead range

0.5

0.4

0.03

0.03

0.0

!

TABLE 24
DISTRIBUTION OF URINARY ALA VALUES IN 3, 148 CHILDREN WITH NORMAL
LEVELS OF BLOOD LEAD (0-59 pg/100 ml)

URINARY ALA LEVELS (mg/100 ml)
Normal
'l+
2+
3+
4+
5+
(O. 00-0. 99) (1. 00-1. 49) (1. 50-1. 99) (2. 00-2. 99) (3. 00-5'. 99) (6. 00-10. 00)

Number of children in
each urinary ALA range

~ l % ~f children in each
urinary A LA range

2,982

152

12

1

1

947

4.8

0.4

0.03

0.03

0

o.o

TABLE 25
EFFECT OF VARIOUS METALS ON URINARY ALA EXCRETION IN RATS
URINARY ALA ()lg/24 HOURS)a
Compound

·nose
{mg/kg)

Day 1

Day 2

Dal 3

Day 4

Dal 5

33+25

-

37+9

-

39+20

39+17

34+17

35+18

24+7

50

27+11

-

29l+U3

-

366+141

-

346+109

185+228

-

201+152

246+266

10

37+5

-

32+1

39+3

22-+:2

16+6

27+16

44+24

37+4

-

23+8

32+8

-

20+6

24+4

22+3

27+4

Controlb
Le~d

acetate

Tetraethyl lead
Cadmium chloride

·Day 14

Day 0

4.5

-

-

-

-

Barium chloride

15

34+11

35+4

30+27

-

28+11

36+22

31+17

37+15

Ferrous sulfate

100

47+21

-

35+6

32+15

75+33

47+16

51+12

35+9

19

33+19

33+4

36+20

26+21

33+11

33+18

38+15

Zinc chloride

-

a . Data are expressed as mean of 3
b

-

animals·~

-

-

standard deviation.

Each metal with the exception of tetraethyl lead was dissolved in distilled water. A single intraperitoneal injection of 1 ml was used to administer the desired quantity of each metal and a 1 ml
irrtraperitoneal injection of distilled water was used as control. Tetraethyl lead was diluted to the
desired strength with pean~t oil and 1 nil of this solution was acbninistered orally.

TABLE 25 (Continued)
EFFECT OF VARIOUS METALS ON URINARY ALA__EXCRETION IN RATS
URINARY ALA (,µg/24 HOURS)a
Compound
Strontium bromide
Copper sulfate
Arsenic pentoxide
Titanium dioxide

t--1

tn

H:>-

I

Mercuric chloride
Lithium chloride

c

Dose
(mg/kg)

Day 0

Day 1

Day 2

Day 3

Day 4

Day 5

Day 14

500

48+26

-

42+12

-

61+10

47+34

-

46+32

50+27

-

54+30

15

33+14

-

29+21

-

25+18

-

28+19

25+13

24+14

-

34+16

2

40+13

-

52+22

38+12

-

49+38

-

40+20

30+11

-

25+8

500

40+26

34+4

31+16

31+18

50+6

35+19

35+20

37+6

13+8

16c

37+19

20+9

35+2

2
250

On Day 2 anuria occurred in 2 animals.

d

On Day 5 two animals died.

e

By Day 14 all animals had died.

-

-

-

4+4
33+10

-

-

1+0.4
22+5

3d
54+17

-

-

-

e
35+22

TABLE 26
URINARY ALA CONVERSION CHART FOR AO. 5ml ALIQUOT OF URINE

pg ALA per
O. D.

o. 010
0.0~0

0. 030
o. 040
0. 050
o. 060
o. 070
0. 080
0. 090
0.100
0.110
0.120
0.130
0.140
0.150
0.160
0.170
0.180
0.190
0. 200
0. 210
0. 220
o. 230
0. 240
o. 250
o. 260
o. 270
0. 280
0. 290
0. 300
o. 310
0. 320
o. 330
o. 340
0. 350

14. 2ml Final
Reaction Vol. mg%

=
=

=
=
=
=

=
=
=
=
=
=
=
=
=
=
=
=
=
=
=
::

=
=
=
=
=
=
=
=
=
=

=
=
=

0.15
0.40
0.65
1. 00
1. 25
1.50
1. 75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3. 75
4.00
4.25
4.50
4.75
5.00
5.35
5.60
5.85
6.10
6. 35
6.60
6.85
7.10
7.35
7.60
7.85
8.10
8.50
8.75
9.00

=
=
=
=
=
=
=
=
=
=
=
=
=
=
=

=

=
=
=
=
=
=
=
=

=
=
=
=
=
=
=
=
=
=
=

0.03
0.08
0.13
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
I. 00
I. 07
L 12
1. 17
1. 22
I. 27
1. 32
I. 37
l. 42
1. 47
I. 52
1. 57
1. 62
1. 70
1. 75
1. 80

)lg A LA per
)lgALA per
14. 2ml Final
14. 2ml Final
O. D. Reaction Vol. mg% 0. D. Reaction Vol.

0.
0.
0.
0.

o.
0.

o.
o.
0.

o.

0.

o.
o.
0.

o.
0.
0.

o.
o.
o.
0.
0.
0.

o.
o.
o.
0.
0.
0.
0.
0.
0.

o.
0.

o.

360
370
380
390
400
410
420
430
440
450
460
470
480
490
500
510
520
530
540
550
560
570
580
590
600
610
620
630
640
650
660
670
680
690
700

=
=

=
=

=
=
=
=

=
=
=

=
=
=

=
=

=
=
=
=
=

=
=
=
=

=
=
=
=

=
=
=
=

=
=

9.25 =
9.50 =
9.75 =
10. oo =
10. 25 =
10. 50 =
10. 75 =
11.10 =
11. 35 =
11. 60 =
11. .85 =
12.10 =
12. 35 ·=
12. 60 =
13. 00 =
13. 25 =
13. 50 =
13. 75 =
14.10 =
14. 35 =
14. 60 =
14. 85 =
15.10 =
15. 35 =
15. 60 =
15. 85 =
16. 25 =
16. 50 =
16. 75 =
17. 00 =
17. 25 =
17. 50 =
17. 75 =
18.10 =
18. 35 =
155

1.85
1. 90
1. 95
2.00
2.05
2.10
2.15
2.22
2.27
2.32
2.37
2.42
2.47
2.52
2.60
2.65
2.70
2.75
2. 82
2.87
2.92
2.97
3.02
3.07
3.12
3.17
3.25
3.30
3.35
3.40
3.45
3.50
3. 55
3. 62
3. 67

0. 710 =
o. 720 =
0. 730 =
0. 740 =
0. 750 ;:: .
0. 760 =
0. 770 =
o. 780 =
0. 790 =
o. 800 =
0. 810 =
0. 820 =
0. 830 =
0. 840 =
o. 850 =
0. 860 =
0. 870 =
0. 880 =
o. 890 =
0. 900 =
0. 910 =
0. 920 =
0. 930 =
o~ 940 =
0. 950 =
~. 960 ~
0. 970 =
0. 980 =
0. 990 =
~.000 =
ti.. 100 =
~. 200 =
t 300 =
L400 =

mg~

18.60 = 3. 72
18. 85 = 3. 77
19.10 = 3. 82
19. 50 = 3. 90
19. 75 = 3. 95
20. 00 = 4. 00
20.25=4.05
20. 60 = 4.12
21. 00 =4. 20
21.25 =4.25
21. 50 =4. 30
21. 85 = 4. 37
22. 25 =4. 45
22. 60 =4. 52
23. 00 =4. 60
23. 35 = 4. 67
23. 60 = 4. 72
24. 00 = 4. 80
24. 35 = 4. 87
24. 75 =4. 95
25.10 = 5. 02
25. 35 = 5. 07
25.75=5.15
26. 25 = 5. 25
26. 60 = 5. 32
27. 00 = 5. 40
27.35=5.47
27. 75 = 5. 55
28. 10 = 5. 62
28. 50 = 5. 70
32. 50 = 6. 50
37. 00 = 7. 40
41. 60 =8. 32
46.25=9.25

TABLE 27

CLASSIFICATION OF URINARY ALA LEVELS IN TERMS OF THEIR
RELATIONSHIP TO LEAD EXPOSURE IN CHILDREN

Urinary A LA Range
(mg/100 ml)

o. 00

- 0. 99

Urinary ALA Code

Normal

Relationship to
Lead Exposure*

None

1. 00 - 1. 49

1+

Moderate

1. 50 - 1. 99

2+

Heavy

2. 00 - 2. 99

3+

Severe

3. 00 - 5. 99

4+

Critical

6. 00 - 10. 00

5+

Overwhelming

* Terms

employed were arbitrarily selected.
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